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ABSTRACT 
 
Herpes simplex viruses (HSV) establish latent infections in sensory 
neurons of their host and are maintained in this state by little understood 
mechanisms that, at least in part, are regulated by signalling through nerve 
growth factor (NGF) and its receptor tropomyosin related kinase, trkA.  Previous 
studies have demonstrated that Zhangfei is a transcriptional factor that is 
expressed in differentiated neurons and is thought to influence HSV replication 
and latency. Zhangfei, like the HSV trans-activator VP16 and Luman, binds the 
ubiquitous nuclear protein host cell factor (HCF) inhibiting the ability of VP16 
and Luman to initiate HSV replication.  
 
Recently, Brn3a, another neuronal factor thought to influence HSV 
latency and reactivation was found to possess an HCF-binding domain and 
could potentially require HCF for activity. The neuronal POU IV domain protein, 
Brn3a, among its many regulatory functions has been described as an enhancer 
of the NGF receptor trkA, during development in mouse. I therefore investigated 
the possible link between Brn3a, TrkA, NGF signaling, HCF, Zhangfei and HSV-
1 latency and reactivation. I hypothesized that Zhangfei would also suppress the 
ability of Brn3a to activate the expression of TrkA and that this would have an 
impact on NGF-TrkA signaling and, consequently on HSV-1 reactivation from 
latency. 
 
My first study determined which Brn3a/trkA promoter interactions were 
important for trkA transcription. I constructed a plasmid that contains 1043 base 
pairs of genomic sequences that extend from 30 nucleotides upstream of trkA 
coding region. In contrast to previous data, a short 190 bp region that lies 
proximal to the trkA initiation codon was sufficient for Brn3a trans-activation in 
NGF-differentiated PC12, Vero and human medulloblastoma cells. At least two 
portions of the 190 bp fragment bind to Brn3a. In addition, Brn3a increased 
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endogenous levels of trkA transcripts in PC12 cells and initiated trkA expression 
in medulloblastoma cells, which normally do not express trkA.  
 
The second step was to determine the effects of HCF and Zhangfei 
association with Brn3a on trkA trans-activation. I found that Brn3a required HCF 
for activating the trkA promoter and that Zhangfei has a suppressive effect over 
Brn3a-trkA activation in non-neuronal cells. In sympathetic neuron-like NGF-
treated PC12 cells, Zhangfei did not suppress the ability of Brn3a to activate the 
TrkA promoter, however, Zhangfei was able capable of inducing the expression 
of TrkA in the absence of Brn3a. Both Brn3a and Zhangfei induced the 
expression of endogenous trkA in PC12 cells. 
 
Since Vero and PC12 cells are not from human origin I wanted to 
examine the ability of Zhangfei to induce trkA transcription in medulloblastoma 
cells, that because of its tumor nature do not express trkA. TrkA transfections in 
these cells have shown to drive them to cell arrest or apoptosis.  Since Zhangfei 
is not express in medulloblastoma tumors I then used ONS-76 medulloblastoma 
cells as a model to determine Zhangfei’s envolvement in the NGF-trkA signaling 
pathway. 
 
 I show herein that in ONS-76 medulloblastoma cells resveratrol, an 
inducer of apoptosis and  differentiation, increased the expression of Zhangfei 
and trkA as well as Early Growth Response Gene 1 (Egr1), a gene normally 
activated by NGF-trkA signalling. ONS-76 cells stop growing soon after 
treatment with resveratrol and a portion of the cell undergo apoptosis. While the 
induction of Zhangfei in resveratrol-treated cells was modest albeit consistent, 
the infection of actively growing medulloblastoma cells with an adenovirus 
vector expressing Zhangfei mimicked the effects of resveratrol. Zhangfei 
activated the expression of trkA and Egr1 and caused these cells to display 
markers of apoptosis. The phosphorylation of Erk1, an intermediate kinase in 
the NGF-trkA signaling critical for differentiation, was observed in Zhangfei 
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infected cells, supporting the hypothesis that Zhangfei is a mediator of trkA-NGF 
signaling in theses cells leading either to differentiation or apoptosis. Binding of 
HCF by Zhangfei did not appear to be required for this effect as a mutant of 
Zhangfei incapable of binding HCF was also able to induce the expression of 
trkA and Egr1.  
 
In in vivo and in vitro models of HSV-1 latency, the virus reactivates when 
NGF supply to the neuron is interrupted. Based on the above evidence 
Zhangfei, in HSV-1 latently infected neurons, would have the ability to prolong a 
state of latency by inducing trkA expression allowing the activation of NGF-trkA 
signaling pathway. Since NGF is produced by many cell types it is possible that 
reactivation is triggered not by a decrease in NGF but by a down-regulation of 
TrkA expression.Therefore, if Zhangfei expression is suppress the trkA signaling 
could be interrupted or shifted towards apoptosis signaling, this would allow 
neuronal HCF-binding proteins like Luman, which can activate HSV IE 
expression, to initiate HSV IE expression and subsequently viral replication. 
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1.  INTRODUCTION  
 
1.1 Herpes Simplex virus 
 
Herpes Simplex virus type 1 (HSV-1) causes recurrent lesions on 
epithelial surfaces (reviewed in (Roizman, 2001, Efstathiou and Preston, 2005). 
The virus uses two complementary strategies to avoid immune surveillance 
while maintaining itself in its primary host and continuing the chain of infection to 
other hosts.  Initial infection of epithelial cells by HSV leads to active replication 
of the virus. Destruction of adjoining cells and the response of the host to 
infection lead to characteristic “cold sores”. The virus also infects sensory 
neurons innervating the site of viral replication. The viral genome is delivered by 
retrograde axonal transport to the neuronal cell body in sensory ganglia where it 
establishes a latent infection. Periodic reactivation from latency, in response to a 
variety of stressors, leads to replication of the latent virus in the neuron. 
Anterograde axonal transport of virus to epithelial surfaces and replication in 
epithelial cells causes recurrent lesions and potential dissemination to other 
hosts. 
 
1.1.1   Lytic infection 
Expression of viral genes during lytic infection in epithelial cells is 
temporally regulated so that the approximately 80 viral genes involved can be 
categorized as Immediate Early (IE or α), Early (E or β) and Late (L or γ) 
depending on when in the replicative cycle they are expressed. Since the 
efficient expression of E and L genes depends on IE gene products, these 
regulatory proteins are crucial for the progression of the lytic cycle. 
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1.1.1.1 Initiation of the lytic cycle by VP16, Host Cell Factor and Oct-1  
Initiation of the transcription of the IE genes is induced by the assembly 
of a multi-protein complex made up of virion protein 16 (VP16) and two cellular 
proteins: Oct-1 and Host Cell Factor (HCF). Oct-1 is a Pit-1, Oct-1, Unc-86 
(POU) homology domain containing transcription factor that is involved in 
histone, immunoglobulin and small nuclear RNA gene expression.  HCF 
regulates cellular proliferation and may have other roles as well. VP16 is 
synthesized in the late stages of lytic infection and is incorporated into the 
tegument of the virion. Upon subsequent infection of cells by the virus, VP16 is 
released into the cell where it combines with HCF. HCF promotes the nuclear 
translocation of VP16 (LaBoissiere et al., 1999) and acts as a co-activator of 
VP16 (Luciano and Wilson, 2002). The VP16-HCF heterodimer then recognizes 
the POU domain of Oct-1 bound to TAATGARAT (where R is a purine) motifs 
present in multiple copies in the promoters of all HSV IE genes. The activation 
domain of VP16 interacts with several components of the transcription 
machinery leading to the expression of IE genes. Immediate Early proteins 
subsequently regulate the expression of the E and L genes (reviewed in 
Roizman, 2001). 
 
1.1.1.2 Virion Protein 16 (VP16) 
VP16 is an essential structural component of HSV-1 and is also a potent 
activator of viral IE gene expression. Recruitment of VP16 to the DNA binding 
complex and its ability to activate transcription are distinct activities located in 
two discrete domains (Triezenberg et al., 1988, Greaves and O'Hare, 1989). 
The amino-terminal portion of the protein contains structural elements that 
interact with HCF and Oct-1. The HCF binding motif (HBM) of VP16 is a four 
amino acid domain, EHTY, which as D/EHxY (where x can be any of several 
amino acids) is conserved in several other viral and cellular HCF binding 
proteins. The acidic carboxy-terminal portion of VP16 is required for 
transcriptional activation since truncations or insertions within the intact protein 
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abolished activation without detectable effect on complex formation (Greaves 
and O'Hare, 1989, Werstuck and Capone, 1989, Regier et al., 1993). 
 
1.1.1.3   Host Cell Factor (HCF) 
Host Cell Factor is a chromatin-associated protein that is present in most 
cells and its structure is conserved in the metazoa. The mature form of HCF is 
derived from a 2035 amino acid precursor, which is processed by internal 
cleavage at a number of specific HCF repeats to give rise to polypeptides with 
molecular masses that range from 110 to 150 kDa. After cleavage, most of the 
amino- and carboxy-terminal portions of the protein remain stably associated by 
non-covalent interactions (Wilson et al., 1993, Kristie et al., 1995). The amino 
terminus of the protein is made up of six related repeats of a motif of about 50 
amino acids located within residues 1-380 (Kristie et al., 1995, Hughes et al., 
1999). This Kelch repeat (named after a Drosophila protein) forms the beta-
propeller structure required for its interaction with VP16. In addition, HCF also 
contains an activation domain in its carboxyl terminus that contributes to VP16 
trans-activation but is not required for complex formation. 
 
Although HCF was initially discovered as a component of the VP16-
induced transcriptional complex it is important for many cellular  processes 
including cell-cycle progression (Goto et al., 1997), cytokinesis (Julien and Herr, 
2003), chromatin structure modification and RNA splicing (Ajuh et al., 2002). 
 
A single amino acid substitution in the HCF Kelch domain in a hamster 
cell line results in a temperature sensitive phenotype (tsBN67). At the non-
permissive temperature the cells cease proliferation after a few cell divisions 
and arrest in the Go/G1 phase (Goto et al., 1997) implying that HCF is required 
for cell cycle progression (Wysocka et al., 2001, Reilly et al., 2002). Consistent 
with this role, HCF also interacts with other proteins that have cell cycle-
regulatory roles. The cell cycle regulatory factor Myc-interacting protein (Miz-1) 
causes cell cycle arrest at G1, and is antagonized by direct interaction with  the 
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cell proliferation mediator c-Myc. HCF functions in a manner similar to c-Myc in 
modulating  Miz-1 function (Piluso et al., 2002). 
 
HCF is associated with spliceosomes and in tsBN67 cells, at the non-
permissive temperature, it fails to associate with splicing snRNPs causing 
inefficient spliceosome assembly and defective splicing. The arrest of these 
cells in the G0/G1 phase  of the cells cycle at the non-permissive temperature 
suggets a connection between the involvement of HCF in splicing and cell-cycle 
progression (Ajuh et al., 2002).  
 
Several cellular proteins, like VP16, interact with the Kelch domain of 
HCF. These proteins all contain the four amino acid HBM  (D/EHxY) present in 
VP16. These proteins include, Luman/LZIP/CREB3 (Freiman and Herr, 1997, 
Lu et al., 1997) and Zhangfei (Lu and Misra, 2000b), E2F4 (Luciano and Wilson, 
2003, Knez et al., 2006) and Krox20 (Luciano and Wilson, 2003). Like VP16 
these proteins require HCF for at least some of their functions. Several other 
potential cellular HCF-binding proteins, including the neuronal transcription 
factor Brn3a, possess an HBM (Luciano and Wilson, 2003) but their actual 
binding to HCF has not been confirmed. More recently, proteins like GA-binding 
protein (GABP) (Vogel and Kristie, 2000), Sp1 (Gunther et al., 2000), a protein 
phosphatase (Ajuh et al., 2000), the nuclear receptor co-regulatory factor PGC-
1 (Lin et al., 2002) and the cell cycle regulatory factor Myc-interacting protein 
(Miz-1) (Piluso et al., 2002) have also  been shown to associate to HCF. These 
proteins do not possess the D/EHxY HBM and associate with parts of HCF 
other than the Kelch domain. 
 
1.1.2. Latent infection 
HSV-1 infects endings of sensory neurons innervating the epithelial site 
of primary infection. The process involves fusion of the viral envelope with the 
axon plasma membrane (Antinone et al., 2006). While the viral envelope and its 
embedded glycoproteins are not required for transport of the virion to the 
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neuronal cell body, they are required for infection of the neuron. The 
glycoprotein E, for instance, has been shown to be essential for targeting the 
virus to the axon initial segment (Wang et al., 2005a). The HSV-1 nucleocapsid 
and tegument are transported to the neuronal cell body in sensory ganglia by 
cellular transport motors traveling along microtubules (Bearer et al., 2000). 
Several proteins of the tegument and capsid interact with components of the 
dynein motor complex in yeast two-hybrid or in  in vitro assays (Kamal et al., 
2000, Chuang et al., 2001, Douglas et al., 2004, Antinone et al., 2006). Of 
these, the capsid protein VP26 interacts at the axon tips with dynein light chains 
(Douglas et al., 2004) suggesting an important role for VP26 in loading the virion 
onto dynein. However, more recent studies (Dohner et al., 2006), have shown 
that VP26 is dispensable for transport. Studies using a reconstituted capsid 
transport system that allows the tracking of fluorescent virions from which 
various components of the virion have stripped, suggest that proteins of the 
inner tegument, VP1-3 and UL37 play a key role in transport (Wolfstein et al., 
2006). The outer tegument, comprising VP13/14, VP22, vhs and US11, is 
probably removed during the initial stages following de-envelopment. 
Interestingly, VP16, which is regarded as a component of the outer tegument, 
remains associated with the inner tegument (Wolfstein et al., 2006). The 
tenacious association of VP16 with the capsid is consistent with the 
observations of Bearer et al (Bearer et al., 2000) who demonstrated retrograde 
axonal transport of GFP-VP16 containing HSV virions. These authors also 
found VP16 to be associated with capsids despite detergent treatment. 
 
1.1.2.1 Establishment and maintenance of latency 
Following infection of the neuron, the HSV genome is released into the 
nucleus and may either enter the lytic cycle or is directed to a latent state 
(reviewed in (Preston, 2000)). While reasons for the suppression of the lytic 
cycle leading to latency have not been clearly established, several lines of 
evidence suggest that a block in IE gene expression leads to the establishment 
of latency (reviewed in (Preston, 2000, Efstathiou and Preston, 2005). This 
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failure to induce IE genes is thought to be the result, in part, of the virus inability 
to assemble the VP16-HCF-Oct-1 complex necessary during lytic replication for 
the activation of IE gene promoters. There are several potential reasons for this: 
the absence or inability of VP16 to reach the neuronal nucleus during axonal 
transport, low levels of Oct-1 (reviewed in Valyi-Nagy et al. 2006), cytoplasmic 
sequestering of HCF in sensory neurons (Kristie et al., 1999) and the presence 
in sensory neurons of other members of the POU family, such as Oct-2, that can 
compete with Oct-1 for binding to TAATGARAT elements (Lillycrop et al., 1991 , 
Lillycrop et al., 1994). 
 
In contrast to lytic replication in epithelial cells the viral genome in latently 
infected neurons is almost completely quiescent. During latency viral proteins 
are not detected, nevertheless a proportion of neurons in sensory ganglia 
harboring latent HSV express a family of viral RNAs, called the latency-
associated transcripts (LATs) (Lachmann, 2003), these are encoded by the 
segment of HSV genome that is complementary to the IE gene ICP0 
(Lachmann, 2003). While LAT contain open codon reading frames no proteins 
derived from these sequences have been reliably detected in neurons. 
 
HSV-1 LAT is believed to enhance the establishment and maintenance of 
latency either by repressing lytic gene expression or by protecting the infected 
neuron from death. Infection of neuronal cell clones that stably express LAT 
results in greatly reduced levels of transcripts for HSV-1 IE genes like ICP0, 
ICP4 and ICP27 (Garber et al., 1997, Peng et al., 2005). As well, LAT deleted 
HSV strains establish latency in fewer neurons in the mouse and rabbit models 
of HSV neuropathogenesis (Thompson and Sawtell, 1997).  
 
Prevention of apoptosis by LAT has been mapped to two regions of the 
gene. These regions are able to interfere with caspase-9 induced apoptosis and 
thereby can influence the number of latently infected neurons (Jin et al., 2003, 
Kent et al., 2003). Recently, LAT was shown to code for a microRNA (miRNA) 
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with an anti-apoptotic role (Gupta et al., 2006). The LAT miRNA accumulates in 
cells transiently transfected with the LAT gene fragment or infected with a wild-
type strain of HSV-1. miR-LAT exerts its anti-apoptotic effect by downregulating 
Transforming Growth Factor β, a potent inhibitor of cell growth and an inducer of 
apoptosis, and SMAD3, which regulates transcription of target genes that have 
important roles in diverse cellular processes.  
 
In contrast to lytic replication, during latent infection the HSV genome is 
assembled into nucleosomal structures. Nucleosomal chromatin-mediated 
eukaryotic genes activation or repression is regulated by histone modification.  
The LAT gene promotes the assembly of heterochromatin on viral lytic gene 
promoters during latency (Wang et al., 2005b, Amelio et al., 2006a).  The only 
gene that is associated with hypoacetylated active chromatin during latency is 
LAT and the LAT promoter is insulated from the hyperacetylated lytic cycle 
genes (Amelio et al., 2006b). 
 
During the establishment of latency in both in vivo and in tissue culture 
systems, the ends of the viral genome become joined, and there is strong 
evidence that the latent genome persists as a nonreplicating circular episome 
(Jackson and DeLuca, 2003, Strang and Stow, 2005).  
 
While viral proteins are not consistently detected in LAT-expressing 
neurons when biochemical techniques are used, sensory ganglia harbouring 
latent HSV contain long lasting CD8+T cells specific for a dominant epitope of 
the HSV glycoprotein B (Khanna et al., 2003). These cells produce γ-interferon 
and other cytokines that can suppress viral replication. These observations have 
prompted a hypothesis that the latent HSV genome is not silent but that IE and 
E viral proteins are produced at low levels. These proteins, especially gB, 
stimulate CD8+ T cells which, via γ-interferon maintain latency by suppressing 
viral replication (Khanna et al., 2004).  
 
  8 
1.1.2.1.1 The role of NGF-trkA signaling in the maintenance of latency 
When sensory ganglia from mice latently infected with HSV are removed 
from the animal and cultured with cells permissive to HSV replication, latent 
virus is reactivated (Hill et al., 1997). Reactivation can be prevented if the 
explanted ganglia are maintained in medium containing the neurotrophin, Nerve 
Growth Factor (NGF) and the effect of NGF can be reversed by treatment with 
specific antibodies (Wilcox and Johnson, 1988). In addition, latent virus can be 
maintained in NGF-treated primate and rodent neurons (Wilcox et al., 1990) and 
in rat pheochromocytoma (PC12) cells (Block et al., 1994). In these cells, HSV 
can be reactivated by NGF-deprivation or treatment with antibodies against 
either NGF or the NGF receptor, the tropomyosin related kinase (trkA). Virus 
can also be reactivated in these cells by treatment with chemicals such as 
hydroxydopamine and colchicine (Wilcox et al., 1990) that either destroy the 
NGF-responsive sympathetic nerve terminal or block the ability of the NGF-trkA 
signaling endosomes to be retrogradely transported, thereby interfering with the 
ability of NGF to signal in the affected neurons. These observations suggest that 
expression of HSV lytic cycle genes in latently infected neurons may be 
suppressed through the action of NGF and trkA (Huang et al., 1999, Huang and 
Reichardt, 2003). 
 
Neurons in sensory ganglia are a diverse population of cells. 
Approximately 40-50% mature sensory neurons express trkA and are 
dependant on NGF for function (Verge et al., 1992, Yang et al., 2000). Although 
all sensory ganglia cells are capable of supporting productive HSV infection, 
some populations are more permissive to latent infection than others. Three 
subpopulations of sensory neurons have been associated with HSV latency in in 
vitro or in vivo studies (Wilcox and Johnson, 1988, Laycock et al., 1994, Yang et 
al., 2000, Jones, 2003): trkA-expressing neurons that transduce nociceptive 
information, those that express the developmentally regulated globoseries 
glycoconjugate SSEA3 and neurons that contain antigen recognized by the 
monoclonal antibodies A5 and KH10. These populations are not mutually 
  9 
exclusive. The A5 immunoreactive neurons are most likely to result in latent viral 
infection and more than 70% of neurons harbouring latent HSV express trkA 
and respond to NGF (Yang et al., 2000). 
 
There is evidence that indicates that the levels of NGF supplied by the 
innervated target cells can mediate NGF-dependent effects on HSV-1 latency. 
NGF-ligand interaction and signal transduction could also be involved in the 
ability of HSV to sense changes that favor reactivation (Grimes et al., 1997) and 
interruption of NGF-trkA signalling by suppression of trkA expression might have 
the same consequence as NGF deprivation (Verge et al., 1992).  
 
1.1.2.2 Reactivation from latency 
In humans many stimuli such as physical or emotional stress, 
hyperthermia, exposure to UV light, menstruation, physical trauma (reviewed 
(Roizman, 2001) surgical manipulation of the trigeminal root ganglion (Tenser, 
1998) and critical illness with prolonged intubation (Bruynseels et al., 2003) 
have been implicated as triggers for the reactivation of latent HSV. Similar 
stimuli can induce reactivation in  animal models of HSV pathogenesis (Sawtell 
and Thompson, 1992). While many stimuli or physiological conditions are 
recognized as inducers of HSV reactivation, the biochemical mechanisms that 
link the stimuli to molecular events in the neuron that lead to the viral replication 
are poorly defined. 
 
1.1.2.2.1 The role of HCF in reactivation 
Although there is little evidence to support this concept, it is logical to 
assume that the mechanism for the initiation of the viral replicative cycle in the 
neuron during reactivation from latency is similar to the mechanism that initiates 
the replicative process in epithelial cells. The three initiating components for IE 
gene expression in epithelial cells are VP16, HCF and Oct-1. Latently infected 
neurons contain no detectable VP16 and while Oct-1 is important for IE 
expression it is not essential for IE induction (Nogueira et al., 2004). HCF, in 
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contrast, does appear to be important for IE expression both in epithelial cells 
and neurons (Narayanan et al., 2005) and may be a critical component of the 
switch from latency to viral replication. In addition to facilitating VP16-mediated 
IE gene induction it also mediates activation by GA binding protein (GABP) 
(Vogel and Kristie, 2000), and Sp1 (Gunther et al., 2000), two cellular factors 
with response elements in the promoters of IE genes. Depletion of HCF in cells 
suppresses IE gene activation by VP16 as well as by GABP and Sp1 
(Narayanan et al., 2005). 
  
While HCF is a nuclear protein in most cells it is located in the cytoplasm 
of sensory neurons in unstressed mice and stress as well as stimuli that induce 
reactivation in the mouse model of latency induce translocation of the protein to 
the nucleus (Kristie et al., 1999). 
 
1.1.3 Host proteins that mimic VP16 in its interaction with HCF 
Since viral proteins, including the virion associated IE gene activator 
VP16, are absent from latently infected neurons it is likely that cellular factors 
lead to the activation of IE gene expression and subsequently to virus 
replication in the neuron. And, since HCF appears to be required for reactivation 
(see above) it is likely that neuronal HCF-binding proteins substitute for VP16 in 
the initiation of viral lytic gene expression. Our laboratory has identified two 
basic leucine zipper (b-Zip) containing transcription factors, Luman and 
Zhangfei, that, like VP16 bind HCF and appear to play a role in HSV latency and 
reactivation (Akhova et al., 2005). 
 
1.1.3.1 Luman 
Luman (also called L-Zip or CREB3), was initially identified in a yeast 
two-hybrid selection system as a cellular HCF-binding protein (Freiman and 
Herr, 1997, Lu et al., 1997). Luman is a type II endoplasmic reticulum (ER) 
imbedded b-Zip protein and a member of the CREB/ATF family of transcription 
factors (Lu and Misra, 2000a). Luman is released from the ER by regulated 
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proteolytic cleavage to relocate to the nucleus where the protein can bind to 
cyclic AMP response elements  (CRE) and unfolded protein response elements 
(UPRE) and activate transcription from promoters containing them (Lu and 
Misra, 2000a, Raggo et al., 2002, Misra et al., 2005). These include CRE in 
promoters of the HSV IE gene ICP0. In addition, Luman, by inducing the 
expression of Herp, is able to promote cell survival against ER stress-induced 
apoptosis (Liang et al., 2006). 
 
Luman interacts with HCF through the tetrapeptide DHTY which is 
homologous to the EHAY binding sequence of HCF with VP16.  While HCF is 
present in the nucleus of most cells, it colocalizes with Luman in the cytoplasm 
of neurons (Lu et al., 1997). While transcripts for Luman are present in many 
tissues, the protein has only been identified in neurons of the trigeminal 
ganglion where it associates, in the cytoplasm, with HCF (Lu et al., 1997).  
 
1.1.3.2   Zhangfei 
Zhangfei was also discovered as a binding partner for HCF in a yeast 
two-hybrid screen of a human cDNA library (Lu and Misra, 2000b). It possesses 
an HBM and binds HCF both in vitro and in vivo. Zhangfei suppresses the 
activity of both Luman (Misra et al., 2005) and VP16 (Akhova et al., 2005) to 
activate transcription. A mutant of Zhangfei that cannot bind HCF was impaired 
in its ability to suppress Luman and VP16 suggesting that HCF is required for 
the effect. The mechanism by which Zhangfei exerts its effect is not known.  
 
Zhangfei is a b-Zip domain containing protein although its basic region 
lacks a crucial asparagine residue required in other b-Zip transcription factors 
for binding DNA. Perhaps as a consequence of this, it does not, as a homo-
dimer, associate with known binding sites for b-Zip factors and neither does it in 
in vitro assays activate promoters containing these elements (Lu and Misra, 
2000b). Recently, however, Zhangfei was shown to dimerize with the b-Zip 
transcription factor ATF4 and enhance its binding to the CRE (Hogan et al., 
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2006). This suggests a role for Zhangfei in the activation of the MEK1-ATF4 
signaling pathway. Zhangfei can also dimerize with the b-Zip protein Xbp1 
(Chauhan, unpublished). Unlike ATF4-Zhangfei dimers, the association of 
Zhangfei with Xbp-1 leads to the suppression of its ability to activate gene 
expression. 
 
Zhangfei and Luman have incompatible b-Zip domains (Vinson et al., 
2002) and do not associate with each other through these motifs. These 
proteins do not appear to bind each other if they are co-synthesized along with 
HCF in vitro (Misra et al., 2005). This suggests that if suppression of Luman by 
Zhangfei requires that the two proteins associate with each other, cellular 
proteins must act as a bridge.  
 
Zhangfei suppresses the ability of VP16 to activate the expression of the 
IE protein ICP0 and, consequently, in Zhangfei expressing cells all temporal 
classes of HSV proteins (IE, E and L) and progeny virus are reduced (Akhova et 
al., 2005). As with Luman, the association between Zhangfei and VP16 can not 
be shown although Zhangfei appears to have a profound effect on the ability of 
VP16 to form a multiprotein complex involving HCF and Oct-1 on TAATGARAT 
elements on IE promoters. 
 
While Zhangfei mRNA is present in several human tissues and cultured 
cell-lines of epithelial and fibroblastic origin, the protein can only be detected in 
neurons in sensory ganglia and in the cerebrum (Akhova et al., 2005). 
 
 
1.2 Signal transduction in neurons in response to NGF 
 
1.2.1 Nerve Growth Factor and its receptors. 
Neurotrophins enhance the viability and differentiation of specific neurons 
of the peripheral and central nervous system (Kaplan and Miller, 2000). They 
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exert their effect by binding to two classes of cell surface receptors: members of 
the tropomyosin related kinase (trk) receptor family  (trkA, trkB, trkC),  known 
also as high affinity receptors, and the  low affinity p75 neurotrophin receptor, a 
member of the tumor necrosis factor (TNF) receptor family.   
 
  Nerve Growth Factor is one of four members of the neutrophin family and 
its cognate receptors are trkA and p75. These two receptors can augment or 
oppose each other. Both are found in most NGF responsive sensory, 
sympathetic and forebrain cholinergic neurons (Parada et al., 1992, Greene and 
Kaplan, 1995, Kaplan and Miller, 2000, Huang and Reichardt, 2003). The p75 
receptor can transmit positive and negative signals regulating survival and death 
events. trkA receptors transmit positive signals such as enhanced survival, 
growth and differentiation of sensory nociceptive and sympathetic neurons 
(Tusher et al., 2001, Ma et al., 2003). p75 can upregulate survival signals when 
NGF secretion is low by enhancing the formation of high affinity binding sites 
between NGF and trkA (Mahadeo et al., 1994). NGF has also been shown to be 
necessary for the maintenance of HSV latency in sensory neurons (see section 
1.1.2.1.1) and its expression pattern may play a critical role in the development 
of specific neuronal cell types (Fedtsova and Turner, 1995, Xiang et al., 1996, 
Artinger et al., 1998, Chiarugi et al., 2002). 
 
1.2.1.1 The role of NGF-trkA in differentiation, survival and development 
In the peripheral nervous system trkA is expressed primarily in small to 
medium diameter nociceptive sensory neurons of trigeminal ganglia, dorsal root 
ganglia and in sympathetic neurons (Martin-Zanca et al., 1990, Crowley et al., 
1994). In the central nervous system trkA is found primarily in basal forebrain 
cholinergic neurons (reviewed in (Lei and Parada, 2007)). trkA-NGF  
interactions in these cells control cell fate, differentiation, survival, proliferation 
and axonal growth. trkA expression in nociceptive neurons and some 
sympathetic neurons continues after birth and signaling through trkA is thought 
to be important for the survival of sympathetic neurons and maintenance of the 
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differentiated phenotype in both these neuronal populations. Absence of trkA 
during development of neurons, results in loss of approximately 75% of 
neurons. Studies in trkA knock-out mice have shown insensitivity to heat and 
pain and greatly reduced numbers of small to medium diameter neurons in 
trigeminal and dorsal root ganglia (Fagan et al., 1996). Mutations in the trkA 
receptor or its ligand NGF also lead to the loss of neurons in the trigeminal 
ganglion due to apoptotic death (Huang et al., 1999). In addition, NGF delivered 
to sensory neurons at the site of injury associated with diseases such as Type 2 
diabetes, is being examined as a therapeutic modality (Sasaki et al., 2004, 
Walwyn et al., 2006).  
 
1.2.1.2 Signal transduction of   NGF-trkA 
The activation of trkA is critical for initiating NGF signal transduction 
(Huang and Reichardt, 2003). NGF binds to trkA molecules causing their 
dimerization and autophosphorylation of tyrosine residues in the Trk cytoplasmic 
domain (Zhou et al., 1994) (Fig.1). trkA phosphorylated residues (Y490, Y674, 
Y675, Y751, and Y785) serve as anchors for binding and activating downstream 
signalling molecules that coordinate neuronal survival and differentiation  
(Kaplan and Miller, 2000, Yuan and Yankner, 2000).  These include the Ras-
Erk, PI3 kinase-Akt and PLCγ-MEK1/2 pathways.  Tyrosine residues at 
positions 490 and 785 appear to be important for activating pathways in sensory 
neurons (Yuan and Yankner, 2000, Huang and Reichardt, 2003). 
Phosphotyrosine 490 interacts mainly with Shc, which provides mechanisms for 
the activation of the Ras-Erk dependent gene transcription and neurite growth 
pathway. Ras also activates RhoA, which in turn inhibits p21CIP–induced cell 
arrest. Phosphotyrosine 751 interacts with the PI3-Akt kinase for cell survival. 
This pathway is mediated either by stimulation of pro-survival factors Bcl-xL and 
NF-κB or by the inhibition of apoptosis through the Caspase cascade (Kaplan 
and Miller, 2000, Yuan and Yankner, 2000, Shimoke et al., 2005). 
Phosphotyrosine 785 interacts with PLCγ and like the phosphotyrosine 490-Shc 
mediated signalling it also activates MEK1/2 induced cell growth. MEK1/2 is, 
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however, phosphorylated by Protein kinase C (PKC). NGF can stimulate cell 
survival by preventing apoptosis induced by a variety of stimuli. These include 
inhibition, by activation of the PI3K pathway (Shimoke et al., 2004, Shimoke et 
al., 2005) of ER stress induced apoptosis (inactivation of caspase-3, -9, –12). 
 
 
 
 
 
 
Figure 1.1. Nerve growth factor signaling through the receptor trkA. 
Representation of trkA signaling pathways found in neuronal cells of different 
origin. Signal transduction causes phosphorylation of downstream proteins that 
will induce (→) or suppress (┴) gene expression. 
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1.2.1.3 Signal transduction by NGF-trkA in neuronal tumor cells   
In addition to the role of NGF-trkA signalling in preserving sensory 
neurons, this pathway may be important in regulating uncontrolled cell division 
in neuroblastomas and medulloblastomas, two childhood neuronal cancers.  
Neuroblastomas are derived from sympathetic neuroblasts of the peripheral 
nervous system and medulloblastomas are embryonic cerebellar neoplasms of 
the central nervous system resembling neuro-epithelial tumors. The presence of 
trkA in neuroblastomas is associated with favorable outcomes in patients and in 
medulloblastomas trkA expression correlates with increased rates of apoptosis 
(Tajima et al., 1998, Eberhart et al., 2001, Ohta et al., 2006). Moreover, 
induction of trkA expression in tumor cells devoid of trkA makes them 
responsive to NGF. NGF-trkA signaling in these cells activates MAPK and 
induces cellular immediate early genes (Egr-1, c-Fos). This leads to either their 
differentiation (Eggert et al., 2000) or to apoptosis through the activation of a 
novel Ras and/or Raf signaling pathway (Muragaki et al., 1997, Chou et al., 
2000). These observations indicate that the response to trkA activation by NGF 
is cell type specific. 
 
1.2.1.4 The activation of trkA transcription  
The 5’ non-coding region of the trkA gene in mouse and human has been 
characterized (Parada et al., 1992, Park et al., 1998). The transcription start site 
is located 70/71 bp and 30-50 bp upstream of the ATG translation initiation 
codon in mouse and human respectively. trkA promoter mutants tested in PC12 
and N2a cell lines showed that the main regulatory region for trkA transcription 
in mouse is located in a 150 bp segment immediately upstream of the 
transcriptional start site (Parada et al., 1992). In the human a 138 bp segment   
lying 30 bp upstream of the trkA transcriptional start site region is the main 
activator of transcription in neuroblastoma cell lines (SH-SY5Y, LA-N-6, IMR32) 
(Park et al., 1998).  In both species these regulatory regions form multiple 
binding complexes indicating the presence of several regulatory elements.  
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In spite of several transcription factors being associated with the 
regulation of trkA transcription (e.g. Brn3a, Klf7, SP1, Runx1, HIPK2) (reviewed 
in (Lei and Parada, 2007)) and  there being compelling evidence that trkA is 
regulated by many physiological and pathological conditions, the molecular 
mechanisms that regulate trkA expression and the cell type specific signaling 
pathways that follow activation have not been identified.  
 
1.2.2 Brn3a, POU domain containing transcription factor 
Brn3a is a member of the POU IV (or Brn-3) subfamily of POU 
transcription factors. These factors are classified according to the similarity of 
their common DNA binding POU domain. The Brn3 subfamily is comprised of 
Brn3a, Brn3b and Brn3c. They have the ability to bind and activate or repress 
transcription through their affinity to octamer promoter sequences (Xiang et al., 
1995, Gruber et al., 1997, Ma et al., 2003).  Brn3a has also been described as a 
potential HCF binding protein (Luciano and Wilson, 2003). The POU domain 
consists of an amino-terminal POU-specific domain (POU IV Box) and a POU 
homedomain at the C-terminus separated by a short flexible linker  region, both 
are highly conserved and contribute to site recognition (Gerrero et al., 1993). 
The structural bipartite POU domain has inherent conformational flexibility 
conferring functional diversity to this class of transcription factors (Phillips and 
Luisi, 2000).  
 
1.2.2.1 Brn3a regulatory roles 
  Brn3a is consistently expressed in a subset of sensory neurons of the 
developing and adult central nervous system as well as in the peripheral 
nervous system (Gerrero et al., 1993, Xiang et al., 1996). In the peripheral 
nervous system Brn3a is expressed in dividing precursor cells of trigeminal 
sensory ganglia. In the central nervous system, Brn3a appears in the very early 
stages of neuron differentiation in midbrain, hindbrain and spinal cord (Fedtsova 
and Turner, 1995, McEvilly et al., 1996). Presence of Brn3a at specific stages of 
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development has shown to be an adequate marker for sensory precursors and 
sensory neuronal cells.  
 
Brn3a has the ability to modify gene transcription by binding directly to 
promoters or indirectly by interacting with other cellular proteins that have 
promoter interactions. The activation of anti-apoptotic (Bcl-2 and Bcl-xL (Smith 
et al., 1998)), differentiation (alpha-internexin (Budhrammahadeo et al., 1995), 
neurofilament (Smith et al., 1997) and synaptic genes (SNAP25 (Lakin et al., 
1995)) is mediated by direct binding of Brn3a to promoter sequences. The 
interaction of Brn3a with other proteins during gene activation is complex. Its 
activating or suppressing effects are dependant on the specific binding protein, 
the specific target gene and the cell type (Hudson et al., 2005). The protein p53 
is an example of Brn3a differential regulation of target genes.  In in vitro 
transfection assays in the ND7 neuronal cell line, known to express Brn3a, p53 
activates transcription of two genes associated with apoptosis; Noxa and Bax. 
Noxa is induced by stress related stimuli and Bax is present during naturally 
occurring apoptosis in neurons of the TG and DRG during development. When 
p53 and Brn3a are co-expressed, cell survival increases as Brn3a suppresses 
the binding of p53 to the promoter of NOXA and Bax apoptotic genes (Hudson 
et al., 2005). In contrast, Brn3a also cooperates with p53 to activate the 
transcription of cyclin dependant kinase p21 increasing its endogenous levels 
and favoring cell cycle arrest (Hudson et al., 2005).  This differential regulatory 
effect of Brn3a on p53 trans-activation of genes suggests the means by which 
Brn3a controls survival and /or differentiation of neuronal cells.  
 
1.2.2.2 Brn3a and trkA transcription  
Brn3a inactivation causes widespread losses of nociceptive neurons 
(Huang et al., 2001) and a significant attenuation of trkA gene expression in 
sensory ganglia (Huang et al., 1999). Recently Brn3a has been described as an 
enhancer of trkA transcription thereby contributing to NGF signaling (Ma et al., 
2003).  Most neurons expressing trkA receptors during early stages of 
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embryonic development are not affected by the absence of Brn3a, however 
after week 12.5 of gestation in mice, absence of Brn3a triggers a total loss of 
trkA receptors and abrupt apoptosis of cells. Only 30% of neurons survive after 
birth, these lack trkA expression and their survival is not dependent on NGF 
(Huang et al., 1999, Ma et al., 2003). While Brn3a does not appear to be 
required for the initiation of trkA expression, it is required for trkA sustained 
expression and protection of sensory neurons from apoptosis (Ma et al., 2003). 
Absence of Brn3a does not reduce the expression of p75, another NGF 
receptor, indicating the Brn3a specifically promotes the expression of the trkA 
receptor (Huang et al., 1999). However, following withdrawal of NGF, over-
expression of Brn3a enhances survival of sensory neurons but not sympathetic 
neurons (Huang et al., 1999, Ensor et al., 2001) indicating that in sensory 
neurons, Brn3a promotion of  survival is only partially dependant on trkA 
signaling pathway. 
 
The activation of trkA transcription by Brn3a was  described by Ma and 
others (Ma et al., 2000). In these studies a 457 bp segment of genomic DNA 
lying upstream from mouse trkA coding sequences that specifies appropriate 
trkA expression during embryogenesis in sympathetic neurons and neurons of 
the TG and DRG was defined (Ma et al., 2000). Within this region several 
potential binding motifs were identified including two sites that associate with 
Brn3a (Ma et al., 2003) and appear to be unique to the trkA promoter. These 
binding sites T(A/T)ATT described for mouse (Ma et al., 2000, Ma et al., 2003), 
are also present in the human trkA promoter sequence (Ma et al., 2003). 
Although rich in A and T residues this motif differs from the consensus Brn3a 
binding domain described by  Xiang et al (Xiang et al., 1995). This consensus 
sequence (A/G)CTCATTAA(T/C)  is recognized by all members of the Brn-3 
POU family in ganglion cells of the vertebrate retina. Subsequently Gruber and 
others (Gruber et al., 1997) described an octamer binding element 
AT(A/T)A(T/A)T(A/T)AT that has a higher affinity  (1000 fold) for Brn3a than the 
consensus described by Xiang for the POU family. In vitro analysis indicates 
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that the binding motif T(A/T)ATT has a lower affinity for Brn3a binding  than  
these consensus octamers and  is required mainly to enhance expression of 
trkA in sensory neurons (Ma et al., 2003).  The information related to the 
relevance of Brn3a on the transcription regulation of trkA is controversial. 
Recently, Lei and others (Lei et al., 2006) showed that the minimal enhancer 
sequence (457bp) in the trkA promoter is not activated by Brn3a alone in 
sympathetic neuron-like cells (PC12) (Lei and Parada, 2007) and that Brn3a 
transcription activation is only possible with the cooperation of the zinc finger 
protein Klf7 (Lei et al., 2006).  
 
 
1.3 Rationale, Hypothesis and Objectives 
 
The main goal of our research group is to determine how HSV-1 “senses” 
stress in the peripheral nervous system and responds by reactivating from 
latency. We have identified two HCF-binding neuronal proteins – Luman and 
Zhangfei - that may play a role in this process. Zhangfei, in an HCF-dependant 
manner, suppress the activity of other HCF-binding proteins, including VP16, 
and inhibits HSV-1 replication. Recently, Brn3a, another neuronal factor thought 
to influence HSV latency and reactivation was found to possess an HCF-binding 
domain. The objective of the work described in this thesis was to explore 
interactions between Brn3a, HCF and Zhangfei in the regulation of HSV-1 
latency and reactivation. 
 
Based on the following observations: 
• NGF is required for the maintenance of HSV latency and deprivation of 
NGF leads to reactivation. 
• HSV establishes latency in neurons that have high affinity receptors 
(trkA) for NGF. 
• Brn3a regulates the expression of the trkA gene. 
• Brn3a has an HCF binding motif that can potentially bind HCF. 
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• Zhangfei suppresses the activation of HCF binding protein VP16 and 
Luman in a HCF dependent manner. 
• Zhangfei is present in neurons. 
 
 
I hypothesized that: 
 
Brn3a binds HCF and Zhangfei suppresses the ability of Brn3a to induce 
the expression of trkA thereby interrupting the NGF/trkA signalling 
pathway in sensory neurons. 
 
 
My objectives were to: 
. 
1) To confirm that Brn3a activates the trkA promoter and identify Brn3a cis-
acting DNA sequences involved in trkA transcription.  
 
2) To determine if Brn3a binds HCF and whether this is required for the trans-
activation of trkA.  
 
3) To determine the effect of Zhangfei on Brn3a trans-activation of the trkA 
promoter.  
 
In the course of my studies I found that in neuronal cells Zhangfei, instead of 
suppressing the ability of Brn3a to activate the trkA promoter, actually activated 
it. I therefore explored this observation further and determined whether Zhangfei 
could be used to induce trkA expression and restore NGF responsiveness in 
medulloblastoma cells that normally do not express trkA. 
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2.1 Abstract 
 
trkA, the receptor tropomyosin related kinase for nerve growth factor 
(NGF), is critical not only for the correct spatial and temporal development of 
sensory neurons during embryogenesis but also for the survival of sensory 
neurons, the differentiation and apoptosis of neuronal tumors and suppression 
of latent herpes simplex virus genomes. While the regulation of the expression 
of trkA is a complex process, the transcription factor Brn3a is known to play an 
important role as an enhancer of trkA transcription during development in the 
mouse. Despite considerable information on the regulation of trkA during 
embryogenesis, the mechanisms by which the expression of trkA is regulated in 
differentiated neurons, or the factors that influence its expression in tumor cells, 
have not been identified. 
 
Since NGF-trkA signalling appears to be important for a variety of 
neuronal functions in differentiated neurons and may play a role in inducing the 
apoptosis or differentiation of neuronal tumors, we initiated studies to determine 
whether Brn3a/trkA promoter interactions may be important in these cells. We 
constructed a plasmid that contains 1043 base pairs of genomic sequences that 
extend to 30 nucleotides upstream of trkA coding region. In contrast to previous 
data, a short 190 bp region that lies proximal to the trkA initiation codon was 
sufficient for Brn3a responsiveness in Vero cells. This region was also sufficient 
for Brn3a trans-activation in NGF-differentiated PC12 cells. At least two portions 
of the 190 bp fragment bind to Brn3a with an affinity high enough to be detected 
in electromobility shift assays. In addition, Brn3a increased levels of 
endogenous trkA transcripts in PC12 cells and initiated trkA expression in 
medulloblastoma cells, which normally do not express trkA.  
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2.2 Introduction 
 
The receptor tropomyosin related kinase trkA is the cognate high-affinity 
receptor for nerve growth factor (NGF) (Huang and Reichardt, 2003, Parada et 
al., 1992). In the developing mouse embryo, trkA is expressed in neural crest 
derived neurons destined to become sensory neurons with cell bodies in 
trigeminal and dorsal root ganglia (Eberhart et al., 2001, Sasaki et al., 2004). It 
is also present in sympathetic neurons. trkA-NGF interactions in these 
developing  cells control cell fate, differentiation, survival, proliferation, axonal 
growth and target innervation (Bibel and Barde, 2000, Huang et al., 1999).  
 
In addition to the role of NGF-trkA signalling in preserving sensory 
neurons, this pathway may also be important in regulating uncontrolled cell 
division in neuroblastomas and medulloblastomas, two childhood neuronal 
cancers. Thus, the presence of trkA in neuroblastomas correlates with 
favourable outcomes in patients (Eberhart et al., 2001, Ohta et al., 2006, Tajima  
et al.,1998). In addition, restoration of trkA expression in medulloblastoma tumor 
cells devoid of trkA makes them responsive to NGF and leads to their 
differentiation or apoptosis (Chou et al., 2000, Eggert et al., 2000, Muragaki  et 
al., 1997). 
 
While the regulation of the expression of trkA is likely complex, the 
transcription factor Brn3a is thought to play an important role.  Brn3a is a POU 
homeodomain containing transcription factor (Guerrero et al., 1993) that is 
expressed in sensory neurons (Artinger et al., 1998, Fedtsova and Turner, 
1995) and the expression of trkA is greatly reduced in Brn3a -/- mice (Huang et 
al., 1999). While it does not appear to be required for the initiation of trkA 
expression, Brn3a is required for its sustained expression and for the protection 
of sensory neurons from apoptosis (Ma et al., 2003).  
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Ma et al. (2003) defined a 457 base pair (bp) segment of genomic DNA 
lying upstream from mouse trkA coding sequences that  specify appropriate trkA 
expression during embryogenesis in neurons of the trigeminal and dorsal root 
ganglia (Ma et al., 2000). They identified several motifs within this region that 
bind neuronal proteins. These include two sites for association with Brn3a (Ma 
et al., 2003). Since NGF-trkA signalling appears to be important for a variety of 
neuronal functions in differentiated neurons, and may play a role in inducing the 
apoptosis or differentiation of neuronal tumors, we initiated studies to determine 
whether other Brn3a/trkA promoter interactions may be important in these cells. 
 
In this article we show that in contrast to cis-acting sequences identified 
as being required for correct spatial expression of the trkA promoter during 
development of the mouse, in differentiated PC12 cells and medulloblastoma 
cells sequences that lie immediately adjacent to the human trkA promoter play 
an important role in activation by Brn3a. In addition, exogenous Brn3a increased 
expression of endogenous trkA in differentiated PC12 cells and restored trkA 
expression in human medulloblastoma cells that normally do not express trkA. 
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2.3 Materials and Methods 
 
2.3.1 Cell Culture  
Cells were grown in 75-cm2 tissue culture flasks. African green monkey 
kidney (Vero) cells were maintained in Dulbecco’s modified Eagle’s medium 
(DMEM, Invitrogen) with 10% newborn calf serum and 1% penicillin-
streptomycin. Rat pheochromocytoma (PC12) cells (provided by D. D. 
Mousseau, University of Saskatchewan) were maintained in Complete Medium 
(CM) containing RPMI 1640 supplemented with 10% horse serum (heat treated 
to inactivate complement), 5% foetal bovine serum, 2 mM glutamine and 1% 
penicillin-streptomycin. PC12 cells were plated at a density of 2 x 106 in 6 well 
collagen coated plates.  To differentiate PC12 cells they were “fasted” in low 
serum media, RPMI 1640 supplemented with 1% of foetal bovine serum and 1% 
penicillin-streptomycin, overnight before treatment with 50 ng/ml  of nerve 
growth factor (NGF, Cederlane Laboratories, Hornby, Ontario, Canada). NGF 
was reconstituted in 0.02% acetic acid in fetal bovine serum before dilution. 
Human medulloblastoma cells, ONS-76 (Yamada et al., 1989), were obtained 
from Michael Taylor (University of Toronto) and grown in DMEM with 10% foetal 
bovine serum and 1% penicillin-streptomycin.  
 
2.3.2 Collagen coated plates 
Six well plates were incubated at room temperature for 1 hour with 2 mls 
of a 0.02N acetic acid solution containing 50 µg/ml (5 µg/cm2)  rat tail collagen 
(VWR CACB354236). Plates were then rinsed with 0.1N sterile PBS and used 
immediately.   
 
2.3.3 Plasmids. 
The plasmid pRK-55, coding for human Brn3a, was a gift from Mengqing 
Xiang (Robert Wood Johnson Medical School). A 1043 bp portion of the trkA 
promoter region was amplified using PCR from HeLa cell genomic DNA (-1073 
to -30 from the trkA initiator codon).  The set of primers shown in figure 1B, 
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which were used to amplify the 1043bp fragment, included a 5’ KpnI restriction 
enzyme site and a 3’ XhoI site to facilitate cloning. The amplified 1043 bp 
fragment was then cloned using a TOPO cloning kit (Invitrogen). After 
confirming the sequence of the cloned DNA, it was transferred to pCAT3basic 
(Clontech), a chloramphenicol acetyltransferase (CAT) reporter plasmid. The 
resulting plasmid was named ptrkA1043. Constructs generated from ptrkA1043 
are shown in Table 2.1. 
 
Constructs Deletion from 1043bp segment Size of  insert 
remaining fragment 
ptrkA338 BssHII-XhoI 378 
ptrkA470 KpnI-XmaIII / ApaI-XhoI 453 
ptrkA+190 KpnI-ApaI 175 
ptrkA-190 ApaI-XhoI 868 
ptrkAM12(-/-) SmaI-SmaI / BssHII-BssHII 650 
ptrkAM1 BssHII-BssHII 824 
ptrkAM2 SmaI-SmaI 869 
Table  2.1. Genomic human   trkA  promoter constructs. Mutant constructs 
were generated from plasmid ptrkA1043. Sequences were deleted by restriction 
endonuclease digestion and recloned by ligating complementary ends or by 
rendering the ends blunt and then ligating them. The size of  the remaining 
fragments   represent only genomic sequence. 
 
2.3.4 Transfections and CAT-reporter assay 
Vero and PC12 cells were transfected using the calcium phosphate 
method as described previously (Chen and Okayama, 1988) with plasmids, 
purified through CsCl gradients. Vero cells were plated at a density of 1x106 
cells in 6 well plates, transfected the next day with 6.5 µg of DNA and harvested 
48 hr later. PC12 cells were seeded at a density of 2 x 106 per well (collagen 
coated 6 well plates) in CM and incubated overnight at 37oC in a 10% CO2 
incubator. The next day, medium was replaced with 1.5 ml/ well RPMI 1640 + 
10% normal calf serum +1% penicillin-streptomycin + 2mM L-glutamine and 
incubated for at least one hour at 37 oC in 5% CO2 incubator. DNA 
concentrations for transfection were 2µg of reporter plasmid, 1µg pCMVBGal 
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and 1.5 µg of pRK-Brn3a DNA/well. After transfection, cells were incubated for 5 
hours in 5% CO2 and then treated with glycerol as follows: cells were rinsed with 
pre-warmed RPMI and then 0.5 ml of pre-warmed 25% glycerol in 2X BES was 
added. After 45 sec, cells were rinsed twice with RPMI 1640 and 2 ml of PC12 
CM. Low serum medium (1% foetal bovine serum) was added instead if cells 
are going to be treated with NGF. The plates were returned to the 10% CO2 
incubator and harvested 48 hr later. To transfect ONS-76 cells, they were plated 
at a density of 2X105 cells per well of a 6-well plate. The next day, 1.5 µg of 
DNA and 6 µl of Lipofectamine 2000 (Invitrogen) were mixed and added to the 
cells overlayed by 2 ml of OptiMEM (Invitrogen) with 10% fetal serum and no 
antibiotics. The cells were analyzed after overnight incubation. 
 
2.3.5 Chloramphenicol acetyl transferase (CAT) assays 
For chloramphenicol acetyl transferase (CAT) assays 250 ng or 1 µg of 
pCMVBGal, a plasmid specifying beta-galactosidase, was added to transfection 
mixtures in Vero and PC12 cells respectively. Lysates were assayed for beta-
galactosidase (Tajima et al., 1998) and for CAT using an enzyme-linked 
immunosorbent assay kit (Roche Applied Science). CAT values were adjusted 
for transfection efficiency using beta-galactosidase values. In figures showing 
the results of the CAT assays, each data point is the average of replicate 
transfections with the bar representing the range. The data are representative of 
at least two, and usually three, independent experiments that gave the same 
results. 
 
2.3.6 RNA preparation and Real time PCR (QPCR) analysis 
Total RNA was extracted from cells in 6 well tissue culture plates using 
Trizol (Invitrogen) as suggested by the manufacturer and dissolved in 20 µl of 
DEPC-treated water. Next, 5 µg of total RNA was used for first strand cDNA 
synthesis using Superscript II reverse transcriptase (Invitrogen). To detect and 
quantitate trkA and other transcripts we used Brilliant SYBR Green QPCR 
Master Mix (Stratagene). Samples were amplified in a Mx3005XP QPCR 
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thermocycler (Stratagene) using the following thermocycle conditions:  samples 
were heated once at 95 °C for 10 min, 40 cycles of 95°C for 30 s, 60°C for 1 min 
and 72°C for  1 min. Data were analyzed using the thermocycler-associated 
software. For each sample, threshold values for the assayed transcripts (trkA, 
Brn3a and Erg1) were normalized for total input RNA concentrations using cycle 
threshold values for transcripts for the “normalizer” house-keeping gene, 
GAPDH. The normalized values in each experiment were compared to a 
“calibrator” sample to determine the relative increase in the amount of a 
transcript. Results were analyzed for significant difference using Student T-
TEST. The primer sets for transcript amplification were used at a final 
concentration of 40 nM. The sequences of the primers were as follows Brn3a-F: 
5’-tggcgtccatctgcgactc-3’; Brn3a-R: 5’- ctcaggttgttcattttctc-3’;trkAcd-F: 5’ - 
gagggcaaaggctctggactcca-3’; trkAcd-R:  5’- agactccgaagcgcacgatg-3’: Gapdh-F: 
5’-gcctcctgcaccaccaactg; Gapdh-R: 5’- gggccatccacagtcttctgg. Following 
amplification the melting curves for the products were generated to ensure that 
the product represented a homogenous species. In addition, the PCR products 
were analyzed by electrophoresis to ensure that a product of the predicted size 
had been generated. The expected sizes of amplified products were 300 bp for 
Brn3a, 300 bp for trkA, and 130 bp for GAPDH. Amplified products were 
visualized by gel electrophoresis and when first optimizing the reactions the 
sequence of the PCR products was determined. 
 
2.3.7 Electrophoretic mobility shift assay (EMSA) 
Double-stranded oligonucleotides (Table 2.2) were labeled with 32P and 1 
µl of probe containing 10,000 to 40,000 cpm were incubated in 5X gel shift 
buffer containing 20 mM HEPES-KOH, 0.5 mM DTT, 50 mM KCL and 5 mM 
MgCl2. The 5 x gel-shift buffer was mixed with 4% Ficoll 400, and 1 µl of (1µg/µl) 
poly (dI-dC) (Roche), and 1 µl (1.5 µg) purified GST-Brn3a or GST protein. 
Finally, water was added to a total volume of 20 µl. The mix was incubated on 
ice for 40 minutes. For competition assays, 100X of unlabeled double-stranded 
oligonucleotides were mixed with radiolabeled probes. Electrophoresis was 
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done using 6% non-denaturing polyacrylamide gels in 0.5 x TBE buffer at 4°C at 
a constant voltage (150 V) for 3 hours. Gels were then dried and either 
autoradiographed on Kodak X-OMATR film or using a Typhoon Trio (GE 
Healthcare) multi-purpose scanner. 
 
Oligo 
name 
Sequence 5’ to 3’ Size (nt) 
1-F Cctaacaggggagggggcagaggggggggcgtcagagagt 40 
1-R Actctctgacgcccccccctctgccccctcccctgttagg 40 
24-F Aggggggggcgtcagagagtaggaagcgggtggagaagag 40 
24-R Ctcttctccacccgcttcctactctctgacgcccccccct 40 
40-F Aggaagcgggtggagaagaggggcaaggcggggccgggcg 40 
40-R Cgcccggccccgccttgcccctcttctccacccgcttcct 40 
60-F Gggcaaggcggggccgggcgggggccgctggctccgccct 40 
60-R Agggcggagccagcggcccccgcccggccccgccttgccc 40 
80-F Ggggccgctggctccgccctttcctggcggctgggtcttt 40 
80-R Aaagacccagccgccaggaaagggcggagccagcggcccc 40 
100-F Ttcctggcggctgggtctttaacaccgcccagcgcacatg 40 
100-R Catgtgcgctgggcggtgttaaagacccagccgccaggaa 40 
120-F Aacaccgcccagcgcacatgtcgggggaggcctggcagct 40 
120-R Agctgccaggcctcccccgacatgtgcgctgggcggtgtt 40 
140-F Tcgggggaggcctggcagctgcagctgggagcgcacagacgg
ctg 
45 
140-R Cagccgtctgtgcgctcccagctgcagctgccaggcctcccccga 45 
HM1-F Tctaagagatctattaatttcttcacgaataaatcgatgc 40 
HM1-R Caagagcatcgatttattcgtgaagaaattaatagatct 39 
HM2-F  Gttctacctaacttactacaagtgacatgctcactcccctaggc 44 
HM2-R Cgcgtgcctaggggagtgagcatgtcacttggagtaagttaggt 44 
  
Table 2.2. Overlapping oligonucleotides corresponding to 190 bp of the trkA 
proximal promoter sequence used for electromobility shift assay. 
 
 
 
2.3.8 Purification of GST-Brn3a fusion protein 
The GST-Brn3a (-13) fusion protein does not include the first 13 amino 
acids of the Brn3a coding sequence.  These amino acids have been shown not 
to affect Brn3a’s biological activity. Escherichia coli BL21 competent cells were 
transformed with a plasmid expressing GST-Brn3a.  500 ml of cell culture at 
OD600= 0.6 was induced
 to express the fusion protein with 1 mM isopropylthio-b-
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D-galactoside for 4 hours. The cell pellet was resuspended in lysis buffer (Tris, 
0.01M, pH 7.5; EDTA, 0.001M, sodium chloride, 0.15M; 15 TritonX-100, 
Protease Inhibitor Cocktail [Roche Molecular Biochemicals]; 0.25 mg egg-white 
lysozyme) and disrupted by sonication on ice. The supernatant was purified 
using Glutathione-Sepharose 4B beads (GE Healthcare). Cells transformed with 
pGEX-KG, the control plasmid expressing only GST, were processed 
simultaneously. 
 
2.3.9 Antibodies and Immunoblot 
The fusion protein GST-Brn3a (-13) was produced in Escherichia coli 
BL21 (DE3) (Novagen) and purified by using glutathione-Sepharose beads 
(Amersham Pharmacia) as described previously (Park  et al., 1998). Antibodies 
were produced at the University of Saskatchewan Animal Resources Centre by 
immunizing rabbits with about 150 µg of protein in Freund's complete adjuvant 
as described previously (Muragaki et al., 1997). The anti-Brn3a serum 
specifically detects Brn3a in Western blots of in vitro-synthesized Brn3a (TnT, 
Promega) and lysates of transfected mammalian cells (data not shown). 
Procedures for immunoblotting were as previously described (Akhova et al., 
2005). 
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2.4 Results 
 
  The 457 bp segment of DNA identified by Ma et al. (2000) as sufficient 
for appropriate trkA expression   during mouse enbryogenesis contains binding 
sites for many transcription factors.  Within this segment the authors identified 
two sites for the binding of Brn3a (Ma et al., 2003). Since NGF-trkA signalling 
appears to be important for a variety of neuronal functions in differentiated 
neurons and may play a role in inducing the apoptosis or differentiation of 
neuronal tumors, we initiated studies to determine whether other Brn3a/trkA 
promoter interactions may be important in these cells. 
 
Using PCR we amplified a 1043 bp region of DNA that lies upstream from 
the coding sequences for human trkA. This fragment contains regions 
homologous to the 457 bp DNA segment important in mice, including the 
putative Brn3a-binding motifs (Fig 2.1B). An analysis of the sequence of the 
amplified fragment showed that it was similar to the corresponding portion of the 
mouse genome (66%) with almost perfect sequence identity for the putative 
Brn3a-binding sites (Fig 2.1C). To assess the ability of the DNA fragment to 
function as a promoter, we cloned it upstream of the coding sequences of the 
reporter protein CAT in pCAT3Basic. We refer to this construct as ptrkA1043. 
 
2.4.1 Brn3a can activate trkA proximal promoter sequences 
To determine if the trkA upstream sequences could respond to Brn3a, we 
transfected Vero cells with ptrkA1043 and varying amounts of a plasmid that 
expresses Brn3a. For our preliminary experiments we chose Vero cells because 
these Green Monkey kidney cells, which have a fibroblastic phenotype, express 
no Brn3a or trkA (results not shown) and would be unlikely to express other 
neuron specific transcriptional factors. Figure 2.2 shows that Brn3a activated 
expression of CAT over a hundred fold in a dose-dependent manner. To 
determine if the two putative Brn3a sites or other regions of the DNA fragment 
were important for activation, we constructed a series of reporter plasmids from 
  45 
which various portions of the fragment had been deleted (Fig 2.3). While 
deletion of the proximal motif, M2 (ptrkAM1, Fig 2.3) suppressed activation by 
about 50%, deletion of the distal site, M1 (ptrkAM2, Fig 2.3), or simultaneous 
deletion of both sites (ptrkAM1/2(-/-)) had relatively little effect.  It is puzzling that 
while deleting sequences that include M1 and M2 (ptrkAM12(-/-)) has no effect 
on activation, deletion of M1 or M2 by itself have less activation than both of 
them together. I am not sure of the events affecting theses deletions. The most 
profound effect was caused by the deletion of the 190 bp segment that lies 30 
bp upstream from the coding sequences of trkA (see constructs ptrkA-190, 
ptrkA470 and ptrkA338). A construct that contained only these sequences had 
almost the same level of activity as the entire 1043 bp fragment (see construct 
ptrkA+190). Interestingly, this 190 bp segment does not contain sequences 
homologous to the 457 bp region found to be important during development in 
mice.  
 
To determine if the 190 bp fragment could bind Brn3a, we examined 
interactions between the DNA fragments and purified recombinant fusion protein 
made up of GST and Brn3a. In electromobility shift assays, while purified GST 
alone had no effect on the mobility of the fragment (not shown), GST-Brn3a 
retarded the mobility of the radioactively labeled fragment to reveal two bands 
(C1 and C2 in lane 2, Fig 2.4A). An excess of unlabelled fragment inhibited the 
formation of these complexes (lane 3) and inclusion of antiserum against GST-
Brn3a retarded their mobility further (lane 4). These results show that the 190 bp 
fragment contained one and possibly more sites for binding Brn3a. 
 
To identify which portion of the 190 bp fragment bound Brn3a, we 
repeated the electromobility shift assays with overlapping 40 bp double-
stranded oligonucleotides spanning the 190 bp fragment (Fig 2.5A). We also 
included oligonucleotides representing HM1 and HM2, human sequences 
containing homologues of the putative mouse Brn3a binding sites (M1 and M2) 
described earlier by Ma et al. (2000). HM1 specifically bound Brn3a (Fig 2.5B 
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lane 2) while there was no specific binding for HM2. Four of the oligonucleotides 
representing the 190 bp fragment appeared to form complexes with Brn3a. A 
gel showing analysis of oligonucleotides 40 and 60 is shown in figure 5B. Using 
a phosphor-imager and image analysis software we calculated the amount of 
radioactivity in the retarded bands (Brn3a-DNA complexes, * in Figure 2.5B) 
from the various oligonucleotides expressed as a percentage of unbound 
radioactivity (Fig 2.5C).  Our results suggest that Brn3a binds to at least two 
regions of the 190 bp fragment (denoted by asterisks in Fig 2.5A). 
 
2.4.2 Effect of NGF induced differentiation and exogenous Brn3a on the 
expression of endogenous trkA in PC12 cells 
To determine if our observations in Vero cells for Brn3a activation of the 
190 bp fragment were valid for neuronal cells, we examined PC12 cells. These 
are rat pheochromocytoma cells that differentiate into sympathetic neuron-like 
cells when treated with NGF and low concentrations of serum. They have been 
used extensively as an in vitro model to study ligand-receptor interactions and 
cellular differentiation in response to NGF (Greene and Tischler, 1976, Schubert 
and Whitlock, 1977). We first measured the level of trkA and Brn3a transcripts in 
PC12 cells over six days of NGF treatment. The levels of trkA transcripts in 
these cells increased (Fig 2.6A, B day 0, 4, 6 in lanes 1, 2, and 3, respectively) 
in response to NGF while levels of Brn3a decreased (Fig 2.6A). We confirmed 
progressive differentiation of cells by the detection of increasing levels of 
neurofilament, a marker for differentiation (Fig 2.6C day 0, 4, 6 in lanes 1, 2, and 
3, respectively). We next transfected NGF treated and mock-treated PC12 cells 
with a plasmid expressing Brn3a. Forty-eight hours after treatment, NGF treated 
cells (+) expressing exogenous Brn3a (when compared with NGF-treated cells 
transfected with an empty vector, pcDNA) showed a 25-fold increase in the level 
of trkA transcripts (Fig 2.6D). There was no such increase in mock-treated cells. 
NGF treated cells expressing Brn3a are designated as (+) and all transfected 
with an empty vector as (-) in figure 6D. 
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We next examined PC12 cells to determine if the 190 bp proximal trkA 
promoter was active in these cells. NGF treated or mock-treated cells were 
transfected with the empty reporter plasmid (pCAT3basic) or ptrkA+190. The 
190 bp fragment was active in both NGF-treated and mock-treated PC12 cells 
(Fig 2.7A), indicating that in these cells the 190 bp fragment has a relatively high 
level of basal activity. This is in contrast to Vero cells, where in the absence of 
activators such as exogenous Brn3a, the 190 bp fragment has almost no activity 
when compared with the empty reporter plasmid, pCAT3basic (not shown). 
Despite high the levels of basal activity in NGF-treated PC12 cells, ptrkA+190 
was activated almost eight fold by exogenous Brn3a (Fig 2.7B). When PC12 
cells were transfected with a plasmid lacking the proximal promoter (trkA-190), 
no activity was observed in the presence or absence of NGF, indicating that 
trkA+190 is responsible for trkA gene activation by Brn3a (Fig 2.7C). 
 
2.4.3 Activation of trkA in medulloblastoma cells 
Medulloblastomas are childhood neuronal cancers that do not normally 
express trkA. However, if medulloblastoma cells are induced to express trkA 
they become responsive to NGF-trkA signalling (Chou et al., 2000, Fedtsova 
and Turner, 1995, Sacristan et al., 1999) and this is associated with a 
favourable prognosis. We examined the ONS-76 medulloblastoma cell line, 
which was derived from a large cerebellar tumor in a two-year old girl (Yamada 
et al., 1989). The cells express both glial and neuronal markers and can be 
induced to differentiate into neuron-like cells by treatment with dibutryl cyclic 
AMP (Xiang et al., 1995, Lakin et al., 1995). ONS-76 cells were transfected with 
a plasmid expressing Brn3a or an empty vector (pcDNA) and examined for trkA 
transcripts. Cells transfected with pcDNA contained low or undetectable levels 
of Brn3a transcripts and low levels of trkA.  Transfection with a plasmid 
expressing Brn3a caused a dramatic increase in the levels of trkA transcripts in 
these cells (Fig 2.8A). We next determined if the trkA proximal promoter 
(Trk+190) was active in these cells.  The reporter plasmid was activated 2 fold in 
response to exogenous Brn3a (P≤0.007) (Fig 2.8 B,C) and the promoter 
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lacking the 190bp of the proximal promoter (ptrkA-190) failed to activate 
transcription of the reporter plasmid. 
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2.5 Discussion 
 
Nerve growth factor and its high-affinity receptor trkA play important roles 
in cell fate determination, neuronal survival, differentiation and growth (Bibel and 
Barde, 2000, Crowley et al., 1994, Huang and Reichardt, 2003, Martin-Zanca et 
al., 1990). trkA is normally expressed in small to mediuml-diameter nociceptive 
sensory neurons in dorsal root and trigeminal ganglia and also in sympathetic 
neurons (Huang and Reichardt, 2003, Huang et al., 1999, Parada et al., 1992). 
It is also required for the survival and function of sensory neurons after birth, for 
the suppression of the growth of neuronal tumors (Chou et al., 2000, Eberhart et 
al., 2001, Eggert et al., 2000, Muragaki  et al., 1997, Ohta et al., 2005, Tajima  
et al.,1998 Liu et al, 1996, Martin-Zanca et al., 1990) and in the maintenance of 
Herpes simplex virus latency (Hill et al., 1997, Kriesel, 1999, Laycock et al., 
1994, Wilcox et al., 1990). Despite extensive information on trkA regulation 
during embryogenesis, little is known about the mechanisms that regulate trkA 
expression in differentiated neurons or neuronal tumors.  
 
Ma et al. (2000) identified a 457 bp region of DNA as the minimal 
enhancer required for the proper spatial and temporal expression of trkA in 
trigeminal, dorsal root and sympathetic ganglia in mice during development (Ma 
et al., 2000). In addition to two binding sites for Brn3a, this enhancer contains 
binding sites for several other transcription factors. While their studies indicated 
that mutation of each Brn3a-binding site alone had a relatively minor effect on 
trkA function, simultaneous mutation of both significantly reduced trkA 
expression indicating that although the two sites are functionally redundant, they 
are important for maintaining trkA enhancer function.  
 
To determine how Brn3a might influence trkA expression in differentiated 
neurons, we examined a 1043 bp DNA segment of human genomic DNA that 
included the region corresponding to the 457 bp region identified by Ma as the 
developmental minimal enhancer. We initially examined the ability of Brn3a to 
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stimulate transcription from the 1043 bp DNA fragment in non-neuronal Vero 
cells. Since these cells do not express trkA, we could use them as a “black box” 
to eliminate effects by neuron-specific transcription factors and concentrate on 
the effects of exogenously supplied Brn3a alone. While the 1043 bp fragment 
did indeed respond to Brn3a, the two putative Brn3a sites appeared to not be 
required for its activity.  
 
We found that Brn3a was not able to bind to the 3’ binding motif (M2, 
HM2 in Fig 2.5) in the minimal enhancer. While Brn3a did bind the 5’ motif (M1, 
HM1 in Fig 2.5), this motif did not contribute to reporter gene activation in either 
a non-neuronal cell line (Vero, Fig 2.3) or in sympathetic neuron-like cells 
(PC12, results not shown). These data are consistent with Ma et al’s (2000) in 
vivo studies in which expression of trkA was not completely suppressed when 
either site was mutated (Ma et al., 2003). In addition, our results are also 
supported by those of Lei and others (Lei et al., 2006) that showed that the 
minimal enhancer is not active in sympathetic neuron-like cells. These authors 
found that in PC12 cells the trkA minimal enhancer could not be activated by 
exogenous Brn3a unless the cells were also transfected to co-express the 
transcription factor Klf7. This indicates that in vivo binding of Brn3a to these 
sites in the minimal enhancer identified by Ma et al may require its association 
with other proteins.  
 
In contrast to previous data, we found that a short 190 bp region that lies 
proximal to the trkA coding sequence and does not overlap the 457 bp minimal 
developmental enhancer, was sufficient for trkA promoter activation by Brn3a in 
Vero cells (Fig 2.3). This region was also sufficient for Brn3a responsiveness in 
NGF-differentiated PC12 cells (Fig 2.7). At least two portions of the 190 bp 
fragment bind to Brn3a with an affinity high enough to be detected in 
electromobility shift assays (Fig 2.5).  
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Sacristan et al. (1999) and Chang et al (1998) defined the site at which 
transcription of the trkA gene begins (TSS in Fig 2.4B) and the region of the trkA 
promoter that is sufficient to direct accurate transcription in trkA. This region 
encompasses 150 bp upstream of the transcription start site in the mouse and 
138 bp upstream of the start of translation for trkA in humans. These regions are 
a part of the 190 bp identified by us as important for Brn3a responsiveness. In 
addition, in our study exogenous Brn3a was only able to activate the 
transcription of endogenous trkA in the sympathetic-like neuron PC12 (Fig 2.8) 
and not in Vero cells suggesting that this activation is tissue specific and 
requires other cell type specific factors. These data are also consistent with 
those of Sacristan et al (1999) and Chang et al (1998) who found that neuron-
specific proteins bound to regions of the trkA proximal promoter.  An analisis of 
the proximal promoters revealed the presence of multiple recognition binding 
sites for known transcription factors, including ATF, Egr1, Sp1, AP2 and p53. 
Many of them have been associated with either cell differentiation of neuronal 
gene expression.  
 
The 190 bp proximal promoter sequence of the human trkA promoter has 
a high level of homology (82%) with mouse and rat sequences but it also 
contains 34 additional nucleotides (Fig 2.4B). The region does not contain the 
putative motifs for Brn3a found in the trkA minimal enhancer described by Ma et 
al. (2000). However, the 190 bp sequence does have a motif with some 
similarities to Brn3a-DNA binding sequences identified by Xiang et al. (1995) 
and Gruber et al. (1997) (Fig 2.4C). These authors defined two consensus DNA 
sequences for Brn3a binding. The sequences are associated with the activation 
of anti-apoptotic genes (Bcl-2 and Bcl-xL (Smith et al., 1998)), genes linked to 
differentiation (alpha-internexin (Budhram-Mahadeo et al., 1995), neurofilament 
(Smith et al., 1997) and synaptic genes (SNAP25 (Lakin et al., 1995). The 
potential Brn3a binding sequence in the proximal trkA promoter is 40 nt 
upstream of the transcription start site for trkA. It differs by only 2 nt out of 11 nt 
from the one described by Xiang et al. (1995). Moreover, we showed that 
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recombinant Brn3a, in the absence of other cellular proteins, binds to a 
fragment containing this potential binding sequence (Fig 2.5) ruling out the 
requirement for other proteins to interact with Brn3a for transcription activation 
of the trkA proximal promoter.   
 
Since nociceptive neurons depend on trkA and NGF during development 
and trkA is active in differentiated sensory neurons, it is likely that Brn3a has a 
distinctive role in NGF-trkA signalling in these cells. In addition, Brn3a null mice 
not only have aggressive apoptosis of sensory neurons but also have reduced 
trkA transcription.  
 
Because our results showed that Brn3a activates trkA expression, 
restoration of which has been shown to inhibit cell-division in medulloblastomas, 
we determined if Brn3a could induce trkA expression in these cells. As 
expected, Brn3a was able to increase trkA transcription in ONS-76 
medulloblastoma cells (Fig 2.8) and the 190 bp fragment activated reporter 
gene expression. Our results suggest that pharmacological or gene therapy 
procedures that induce Brn3a may lead to regression of these tumors. 
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Figure 2.1. The trkA promoter. A) Consensus Brn3a binding sites (Gruber et 
al., 1997, Xiang et al., 1995) B) A schematic representation of the human trkA-
genomic fragment showing the location of the two putative Brn3a (B) binding 
motifs (M1, M2) identified in the mouse trkA minimal enhancer (Ma et al.,2000, 
2003). The 457 bp segment required for appropriate expression during 
embryogenesis is represented as a solid box. The sequence and location of 
primers P1 and P2 used to amplify human trkA is shown. Nucleotides 
representing sites for the restriction endonucleases KpnI and XhoI were added 
to the 5’ ends of P1 and P2 to facilitate cloning. The amplified fragment extends 
from 30 nucleotides (-30) upstream of the initiator codon for the trkA protein to -
1073 nucleotides. The 1043 bp PCR product obtained with P1 and P2 and DNA 
from human cells was cloned into pCAT3basic. The resulting reporter plasmid 
was called ptrkA1043. C) The putative Brn3a core-binding sequences in the 
minimal enhancer of human and mouse trkA. Asterisks (*) indicate identity. 
Consensus Brn3a binding sites:
(A/G)CTCATTAA(T/C)         GCAT(A/T)A(T/A)T(A/T)AT
Xiang et al, 1995                          Gruber et al, 1997 
Mouse
Human AGATCTATTAATTTCTT           ACCTAACTTACTCCAA
****************            **********-*****
AGATCTATTAATTTCTC           ACCTAACTTATTCCAA
T(A/T)ATT
pTrkA1043
P1 :5’-cgctggtaccTTGAGACGGATGGGTTAGTGC-3’
P2 :5’-attactcgagGCAGCCGTCTGTGCGCTCC-3’
KpnI
XhoI
-1073nt
M1 M2
ATG
P1
P2
-30nt
B
B
M1 M2
A)
B)
C)
B
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Figure 2.2. Brn3a activates the trkA promoter in Vero cells.  Vero (African 
Green Monkey kidney) cells were transfected with ptrkA1043, a reporter plasmid 
with the human trkA upstream sequences linked to the coding sequences for 
chloramphenicol acetyl transferase (CAT) and increasing amounts of a plasmid 
specifying human Brn3a. Each reaction  contained equal amounts of a plasmid 
coding for beta-galactosidase and the total DNA concentration of each reaction 
was adjusted to 5 µg with pcDNA. Cells were harvest 48 hr after transfection 
and CAT and beta-galactosidase activities measured.  The CAT activity in each 
sample was adjusted for transfection efficiency using beta-galactosidase values. 
The CAT activity of samples without Brn3a expressing plasmid (0) was taken as 
1. The results are from a representative experiment. The values are the mean of 
replicates in the experiment. 
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Figure 2.3. Sequences proximal to trkA coding sequences required for 
Brn3a activated transcription in Vero cells. trkA genomic fragments were 
generated by restriction enzyme digestion and re-ligation of the fragment. The 
striped boxes represent the putative Brn3a binding motifs (M1, M2). Horizontal 
lines represent sequences deleted from original clone. The different reporter 
constructs (0.25 µg) or pCAT3basic were introduced into Vero cells together 
with 3 µg of a plasmid specifying Brn3a. A plasmid expressing beta-
galactosidase was included in the reactions to assess transfection efficiency. 
Cells were harvested 48 hr after transfection and   CAT and beta-galactosidase 
measured. CAT activity of the samples is expressed relative to the activity of 
plasmid ptrkA1043 (100%). Values are the means of those obtained from two 
independent experiments, each analyzed in duplicate. Bars indicate the 
standard deviation from the mean.  
0 20 40 60 80 100
pTrkAM1
pTrkAM2
pTrkAM12(-/-)
pTrkA1043
pTrkA+190
pTrkA-190
pTrkA338
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TrkA constructs
Percentage (%)
M1             M2
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Figure 2.4. Brn3a binds directly to trkA proximal promoter sequences. A) 
Electromobility shift assays were performed using 1.5 µg of purified GST-Brn3a 
fusion protein and at least 5 ng of 32P-labeled double stranded oligonucleotides 
representing the 190 bp trkA proximal sequences. Lane 1 contains probe alone, 
lane 2- probe + GST-Brn3a , lane 3- probe + GST-Brn3a + 100 fold excess of 
unlabelled competitor, lane 4- probe + GST-Brn3a + Anti-Brn3a serum. Samples 
were analyzed on a 6% non-denaturing polyacrylamide gel after incubating 
reaction for 40 min on ice. C1 and C2 represent complexes formed with Brn3a 
and the labelled oligonucleotide. Asterisks (* and **) note the location of bands 
with decreased electrophoretic mobility in the presence of antibodies against 
Brn3a. B) Sequence homology of the trkA 5’ proximal promoter region. 
Nucleotide sequence homology between species is indicated by asterisks (*), 
and sequences that are missing in the mouse and rat trkA gene are indicated by 
dashes (-). Potential Brn3a binding site depicted by the bold box and 
transcription start site (TSS) depicted by a thin lined box. Start codon ATG is 
shown in italics and underlined. C) Potential binding site for Brn3a similar to 
consensus binding sequences in other promoters (Smith et al.,1997, Hill et al., 
1997), identical nucleotides at corresponding positions are indicated by 
asterisks (*). 
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Figure 2.4 
**
Free probe
1       2       3        4
C1
C2
*
A)
B)
C)
-1073nt
M1 M2
ATGTSS
Mouse            CTCAAAAGGGGAGGGGGCACTG 680
Rat              CCCGAAAGGGGAGGGGGCACTG 687
Human            CCTAACAGGGGAGGGGGCAGAG 880 
*  * * ************  *
Mouse            GGGGCATTGGCAG---------------------------GCGGGGCGGGGC------GG 707
Rat              GGGGCATCGGCAG---------------------------GCGGGGCGGGGC------GG 714
Human            GGGGGGGCGTCAGAGAGTAGGAAGCGGGTGGAGAAGAGGGGCAAGGCGGGGCCGGGCGGG 940 
****    * ***                       **  **  ********      **
Mouse            GGCCGTGGGTGCCGCCCTCTCCTGGTGGCTAG-TCTTTAACACCGCCCCGCGCACGTGTC 766
Rat              GGCCGTGGGTGCCGCCCTCTCCTGGTGGCTAG-TCTTTAACACCGCCCCGCGCACGTGTC 773
Human            GGCCGCTGGCTCCGCCCTTTCCTGGCGGCTGGGTCTTTAACACCGCCCAGCGCACATGTC 1000 
*****  **  ******* ****** **** * *************** ****** **** 
Mouse            GCGCGAGGCCGGGCGGCGGCAGCTAGGAGCGCACGGACGGCTGCGCGGCCCGAGCAAGGC 826
Rat              GCGCGAGGCCGGGCGGCGGCAGCCAGGAGCGCACGGACGGCCGCGCGGCCCGAGCTAGGC 833
Human            GGGGGAGGCCTGGCAGCTGCAGCTGGGAGCGCACAGACGGCTGCCCCGCCTGAGCGAGGC 1060 
* * ****** *** ** *****  ********* ****** ** * *** **** ****
Mouse            GGGCGCCGCCGCGATGCTGCGAGGCCAGCGG 857
Rat              GGGCGCCGCCGCGATGCTGCGAGGCCAGCGG 864
Human            GGGCGCCGCCGCGATGCTGCGAGGCGGACGG 1091                 
*************************   *** 
TSS
40 60 80
100 120 140
160 180
Brn3a binding motifs Xiang et al, 1995                     
GCTCATTAAC          
*-**-*****         
5’GGTCTTTAACACC- 3’
Consensus Brn3a
Motif TrkA190
  62 
Figure 2.5. Brn3a binding to overlapping oligonucleotides representing the 
proximal trkA promoter. A) Oligonucleotides representing the trkA proximal 
promoter including 132 bp upstream of the site where transcription begins (TSS) 
and 38 bp downstream from it.  Probes were 40 bp long (except probe 140, 
which was 45 bp) and overlapped by 20 bp.   Regions that bound to Brn3a 
(based on results in Fig 2.5C) are indicated by asterisks (*). B)  A representative 
gel. HM1 and HM2 are oligonucleotides representing the human M1 and M2 
motifs. Electromobility shift assays were performed using 1.5 µg of purified 
GST-Brn3a fusion protein (except lanes 1) and at least 5 ng of 32P-labeled 
probes representing sequences within the trkA proximal promoter. Competition 
was performed with an excess of the corresponding unlabeled oligonucleotides 
(lane 3) and GST protein was used to show protein specificity (lane 4). Samples 
were separated on a 6% nondenaturing polyacrylamide gel after incubation  for 
40 min on ice. C)  The proportion of each probe bound by GST-Brn3a. The 
radioactivity in analytical gel was detected using a Typhoon Trio scanner and 
radioactivity in the protein-probe complex and unbound probe was calculated 
using ImageQuant software. Binding to the various probes is expressed as a 
percentage of unbound probes. Human Brn3a only bound to huM1 and to 
probes 40, 100, 120, and 140.  Sequence segments for Brn3a binding in the 
proximal trkA promoter are indicated in (A) by asterisks.  
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Figure 2.5 
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Figure 2.6. Transcription of trkA and Brn3a  in NGF treated PC12 cells. A) 
The expression of endogenous trkA and Brn3a transcripts in PC12 cells treated 
with NGF (50 ng/ml) for 6 days was determined by quantitative real time PCR. 
Level of transcripts is expressed as relative to the day NGF was added (0), 
which is regarded as “1”. B) PCR amplification of trkA and GAPDH day 0, 4 and 
6 after NGF treatment (lanes 1, 2, and 3 respectively).  C) Western blots of 
PC12 (70 ug protein per lane) at day 0, 4 and 6 (lanes 1, 2, 3 respectively) after 
NGF treatment, showing neurofilament (NF) and beta-actin. D) PC 12 cells were 
transfected with pcDNA3 or a plasmid expressing Brn3a (1.5 µg) and relative 
amounts of trkA transcripts measured in NGF treated and untreated cells. Cells 
were harvested 48 hr after NGF treatment. Values represent averages of three 
independent experiments, each done in duplicate. Bars are standard errors of 
means. Statistical differences of (P) are denoted by asterisks (*). 
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Figure 2.7. The trkA proximal promoter (ptrkA+190) is activated in PC12 
cells. A) PC12 cell were transfected with either pCAT3basic or a reporter 
plasmid containing 190 bp of the trkA proximal promoter (ptrkA+190). They were 
then treated for 48 hr with NGF (50 ng/ml).  B) Brn3a activation of the trkA 
promoter in PC12 cells.  PC12 cells were treated with NGF (50ng/ml) for 48 
hours and then transfected with ptrkA+190 or pCAT3basic. The transfection 
mixtures also contained increasing amounts of a plasmid specifying Brn3a. C) 
Cells were transfected either with ptrkA+190 or ptrkA-190 and transfected with 
 Brn3a   expression  plasmid.
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Figure 2.8. Brn3a increases trkA transcript levels in medulloblastoma 
cells.A) ONS-76 medulloblastoma cells were transfected with a plasmid 
expressing Brn3a; trkA transcripts were measured 48 hr later. Values represent 
averages of two independent experiments, each done in duplicate. Bars are 
standard errors of mean. Statistical differences (with P values shown) are 
denoted by asterisks (*). B) Cells were transfected with 0, 250 ng or 750 ng of a 
plasmid expressing Brn3a together with 300 ng of ptrkA+190 or ptrkA-190, CAT 
expression was measured 24 hr later. C) Western blots of samples in ‘B’ probed 
for Brn3a or beta-actin. 
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3.1 Abstract 
 
The replication of herpes simplex virus (HSV) in epithelial cells and 
during reactivation from latency in sensory neurons, depends on a ubiquitous 
cellular protein called Host Cell Factor (HCF). The HSV trans-activator, VP16, 
which initiates the viral replicative cycle, binds HCF as do some other cellular 
proteins. Of these, the neuronal transcription factor Zhangfei suppresses the 
ability of VP16 to initiate the replicative cycle. It also suppresses Luman, 
another cellular transcription factor that binds HCF. Interactions of Nerve 
Growth Factor (NGF) and its receptor tropomyosin related kinase (trkA) appear 
to be critical for maintaining HSV latency. Since the neuronal transcription factor 
Brn3a, which regulates trkA expression, has a motif for binding HCF, we 
investigated if Zhangfei had an effect on its activity. We found that while Brn3a 
required HCF for activating the trkA promoter and Zhangfei suppressed its 
activity in non-neuronal cells, in neuron-like NGF-treated PC12 cells, both Brn3a 
and Zhangfei activated the trkA promoter and induced the expression of 
endogenous trkA. 
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3.2 Introduction 
 
Herpes Simplex virus type 1 (HSV-1) causes recurrent lesions on 
epithelial surfaces. The virus uses two complimentary strategies to avoid 
immune surveillance while maintaining itself in its primary host and continuing 
the chain of infection to other hosts.  Initial infection of epithelial cells by HSV-1 
leads to active replication of the virus. The virus also infects sensory neurons 
innervating the site of viral replication. The viral genome is delivered by 
retrograde axonal transport to the neuronal cell body in sensory ganglia where it 
establishes a latent infection. Periodic reactivation from latency, in response to a 
variety of stressors, leads to replication of the latent virus in the neuron, 
transport of virus to epithelial surfaces were, viral replication causes recurrent 
lesions and potential dissemination to other hosts (reviewed in (Roizman, 2001). 
 
Expression of viral genes during lytic infection in epithelial cells is 
temporally regulated so that the approximately 80 viral genes involved can be 
categorized as Immediate Early (IE or α), Early (E or β) or Late (L or γ) 
depending on when in the replicative cycle they are expressed. Since the 
efficient expression of E and L genes depends on IE gene products, these 
regulatory proteins are crucial for the progression of the lytic cycle. 
 
Initiation of the transcription of the IE genes is induced by the assembly 
of a multi-protein complex made up of the HSV-1 virion protein 16 (VP16) and 
two cellular proteins: Oct-1 and Host Cell Factor (HCF). VP16 recognizes HFC 
through its HCF binding motif (HBM), a four amino acid domain – EHAY – that, 
as the consensus sequence, D/EHxY, is conserved in several cellular and viral 
HCF-binding proteins. The VP16-HCF heterodimer then recognizes the POU 
domain of Oct1 bound to TAATGARAT (R is a purine) motifs present in multiple 
copies in the promoters of all HSV IE genes. The activation domain of VP16 
interacts with several components of the transcription machinery leading to the 
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expression of IE genes. Immediate early proteins subsequently regulate the 
expression of the E and L genes (Jones, 2003).  
 
Following infection of sensory neurons innervating the epithelial site of 
viral replication, the HSV-1 virion is transported along axonal microtubules to the 
neuronal cell body. This process requires proteins present in the viral tegument 
(Bearer and Satpute-Krishnan, 2002, Luxton et al., 2005), a structure that 
surrounds the viral nucleocapsid. The tegument comprises, among other viral 
proteins, VP16. Although the molecular mechanisms that suppress the 
expression of viral lytic cycle genes, as a prelude to the establishment of a 
latent infection in the neuron, have not been defined, they most likely involve the 
blocking IE gene expression (reviewed in (Preston, 2000, Efstathiou and 
Preston, 2005). 
 
During latency no viral proteins can be detected consistently in the 
neuron and the viral genome is silent with the exception of the latency 
associated transcripts which have an anti-apoptotic role (Thompson and 
Sawtell, 2001, Jin et al., 2003, Gupta et al., 2006). A variety of stimuli have been 
shown to result in the reactivation of the latent viral genome. Among these is the 
disruption of Nerve Growth Factor (NGF) induced signaling in the neuron 
(Wilcox and Johnson, 1988, Wilcox et al., 1990, Block et al., 1994, Laycock et 
al., 1994, Hill et al., 1997, Jordan et al., 1998). NGF is a neurotropin that plays 
an important role in the differentiation and survival of sensory neurons (Bibel 
and Barde, 2000, Huang and Reichardt, 2003). Its high affinity receptor in 
neurons is the tropomyosin related kinase (trkA) (Parada et al., 1992, Huang 
and Reichardt, 2003). 
 
Since the latently infected neuron contains no detectable VP16 during 
viral reactivation, the induction of HSV IE gene expression, and subsequently 
the viral lytic cycle, must be mediated by cellular proteins. In addition, since 
HCF appears to be critical for the induction of HSV-1 IE gene expression and, 
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consequently, the induction of the lytic cycle both in epithelial cells and neurons 
(Kristie et al., 1999, Khurana and Kristie, 2004, Narayanan et al., 2005) it is 
conceivable that these viral IE gene-inducing cellular proteins require and bind 
HCF. To examine this possibility our laboratory and others have identified two 
neuronal proteins – Luman (Freiman and Herr, 1997, Lu et al., 1997) and 
Zhangfei (Lu and Misra, 2000b) – that bind HCF and require it for their activity. 
Luman is a ER-anchored basic leucine zipper (b-Zip) protein. When released 
from the ER by regulated proteolysis Luman is a potent transcription activator of 
promoters that contain cyclic AMP and unfolded protein response elements (Lu 
et al., 1997, Raggo et al., 2002, Liang et al., 2006). These elements include 
those in the promoters of the HSV-1 IE gene ICP0 and the latency associated 
transcripts (Lu et al., 1997).  Zhangfei is also a b-Zip protein. In contrast to 
Luman, it acts as a suppressor and reduces gene activation by both Luman 
(Misra et al., 2005) and VP16 (Akhova et al., 2005). Its effect on VP16 leads to 
a profound decrease in viral replication in HSV-1 infected cells that express 
Zhangfei (Akhova et al., 2005). 
 
Among the cellular proteins that possess an HBM (although its ability to 
bind HCF has not been established) is another neuronal transcription factor 
called Brn3a (Fig 3.1). This factor has been shown to be important in regulating 
the expression of trkA during differentiation of sensory neurons in the 
developing mouse embryo (Ma et al., 2000, Ma et al., 2003). We have recently 
identified cis-acting domains in the proximal trkA promoter that bind Brn3a and 
shown that exogenous Brn3a induces the expression of trkA in NGF-
differentiated PC12 cells and in medulloblastoma cells that do not normally 
express trkA (Valderrama, manuscript submitted, Chapter 2 in this thesis). In 
this article we examine Brn3a–Zhangfei interactions to determine if Zhangfei 
can suppress the ability of Brn3a to activate the trkA promoter. We discovered 
that while Brn3a requires HCF for activity and that Zhangfei suppresses its 
activity in non-neuronal cells, however, in neuron-like NGF-differentiated PC12 
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cells, Zhangfei not only did not suppress Brn3a, it was capable of activating the 
expression of trkA in the absence of Brn3a. 
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3.3 Materials and Methods 
 
3.3.1 Cells Culture. 
 Vero cells were maintained in Dulbecco’s modified Eagle’s medium 
(Invitrogen), with 10% newborn calf serum and 1% penicillin-streptomycin. Rat 
pheochromocytoma (PC12) cells (provided by D. D. Mousseau, University of 
Saskatchewan) were maintained in Complete Medium (CM) containing RPMI 
1640,  10% horse serum (heat treated to inactivate complement), 5% fetal 
bovine serum, 2 mM glutamine and 1% penicillin-streptomycin. PC12 cells were 
differentiated with nerve growth factor (NGF, 50ng/ml) and preincubated 
overnight in  RPMI 1640 supplemented with 1% of fetal bovine serum and 1% 
penicillin-streptomycin. 
 
3.3.2 Plasmids. 
 The plasmid pRK-55, coding for human Brn3a, was a gift from Mengqing 
Xiang (Robert Wood Johnson Medical School). Using PCR from HeLa cell 
genomic DNA a 1043 bp portion of the trkA promoter region was amplified (-
1073 to -30 from the trkA initiator codon) and cloned into the chloramphenicol 
acetyltransferase (CAT) reporter plasmid pCAT3basic (Clontech). The resulting 
plasmid was named ptrkA1043. 
 
The construction of ptrkA1043 and ptrkA+190, chloramphenicol acetyl 
transferase (CAT) reporter plasmids with sequences corresponding to the 3’ of 
the human trkA promoter have been previously described (Valderrama and 
Misra, submitted, Chapter 2 this thesis). These reporter plasmids contain 1043 
and 190 base pairs of sequence upstream from the start of transcription of the 
human trkA gene, respectively. Both reporters are activated by Brn3a. The 
reporter pCAT3BATF6 has 5 copies of the unfolded protein response element 
linked to coding sequences for CAT. Plasmids expressing Zhangfei (Lu and 
Misra, 2000b) and Luman (Raggo et al., 2002, Misra et al., 2005) have also 
been described previously. 
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3.3.3 Transfections. 
Vero and PC12 cells were transfected using the calcium phosphate 
method as described previously (Chen and Okayama, 1988). Vero cells were 
plated at a density of 1x106 cells, transfected the next day and harvested 48 hr 
later. PC12 cells were seeded at a density of 2 x 106 per well (collagen coated) 
in CM and incubated overnight at 37oC in a 10% CO2 incubator. The next day, 
medium was replaced with RPMI 1640 + 10% normal calf serum +1% penicillin-
streptomycin + 2mM L-glutamine and incubated for at least one hour at 37 oC in 
5% CO2 incubator. DNA concentrations for transfection were 2µg of reporter 
plasmid, 1.5 µg pCMVBGal and 1.5µg of pRK-Brn3a or Luman (pcLuS221Op, 
which expresses the truncated constitutively active form of Luman) and 2.5µg of 
Zhangfei  or Zhangfei mutant with an altered HBM (pcZFY224A, which cannot 
bind HCF) DNA/well. After 5 hours in 5% CO2 incubation cells were glycerol 
shocked as follows: cells were rinsed with RPMI and then incubated for 45 sec 
with  0.5 ml of pre-warmed 25% glycerol in 2X BES was added. Cells were 
rinsed with RPMI 1640 and incubated in 10% CO2 with  2 ml of PC12 CM or  low 
serum medium (1% foetal bovine serum) if cells were treated with NGF. Cells 
were harvested 48 hr later for analysis. 
 
3.3.4 Chloramphenicol acetyl transferase (CAT) assays. 
For chloramphenicol acetyl transferase (CAT) assays 250ng or 1µg of 
pCMVBGal, a plasmid specifying beta-galactosidase, was added to transfection 
mixtures in Vero and PC12 cells respectively. Lysates were assayed for beta-
galactosidase and for CAT using an enzyme-linked immunosorbent assay kit 
(Roche Applied Science). CAT values were adjusted for transfection efficiency 
using beta-galactosidase values.  In figures expressing data as CAT results 
each data point is the average of replicate transfections.  with the bar 
representing the range. The data are representative of at least two, and usually 
three, independent experiments. 
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3.3.5 Antibodies and Immunoblot and immunoprecipiation.  
Antibodies against Brn3a, Luman and Zhangfei were produced at the 
University of Saskatchewan Animal Resources Centre by immunizing rabbits 
with about 150µg of protein in Freund's complete adjuvant as described 
previously (Misra et al., 1995). The anti-Brn3a serum specifically detects Brn3a 
in immuno-blots of in vitro-synthesized Brn3a (TnT, Promega) and lysates 
mammalian cells transfected to express Brn3a (data not shown). Procedures for 
immunoblotting and in vitro translation of control plasmids and HCF (pSL7) 
plasmid were as previously described (LaBoissiere et al., 1999).  For 
immunoprecipitation, GST-pulldown assays were S35-labelled proteins (Lu and 
Misra, 2000a), and biotinylation proteins (Suzuki et al., 2004). In brief, 35S-
labeled HCF N-C and biotin-labeled Luman, Luman (DHTY78AGTA) or Brn3a 
were synthesized using a TnT system (Promega). 35S-HCF was precipitated 
with GST-Luman, GST-Luman GST-Luman (DHTY78AGTA) or GST-Brn3a 
produced in E. coli, or biotinylated proteins linked to avidin beads. The 
precipitates were washed extensively and analyzed by SDS-PAGE and 
autoradiography. 
 
3.3.6 Quantitative real-time PCR (QPCR). 
 Total RNA was extracted with Trizol (Invitrogen) as suggested by the 
manufacturer. First strand cDNA synthesis using Superscript II reverse 
transcriptase (Invitrogen) was used for QPCR. Brilliant SYBR Green QPCR 
Master Mix (Stratagene) was used to quantitate transcripts of interest. The 
concentration of transcripts in each sample was normalized to a relative amount 
of GAPDH transcripts expressed as cycle threshold (Ct). Samples were 
amplified in a Mx3005XP QPCR thermocycler (Stratagene) using the following 
thermocycle conditions: 95 °C for 10 min, 40 cycles of 95 °C for 30 s, 60 °C for 1 
min and 72°C for  1 min. Data were analyzed using the thermocycler-associated 
software.  The primer sets for transcript amplification were used at a final 
concentration of 40 nM. The sequences of the primers were as follows trkAcd-F: 
5’-gagggcaaaggctctggactcca-3’; trkAcd-R:  5’-agactccgaagcgcacgatg-3’: Gapdh-
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F: 5’-gcctcctgcaccaccaactg; Gapdh-R: 5’-gggccatccacagtcttctgg-3. 
 
3.3.7 Suppression of Zhangfei expression using siRNA. 
 Several portions of the Zhangfei coding regions were assessed for their 
ability as, siRNA, to suppress Zhangfei protein synthesis. Double stranded 
oligonucleotides representing a 5’ overhanging BspI site, 22 Zhangfei-coding 
nucleotides in the sense orientation, a nine nucleotide loop, 22 complementary 
nucleotides, five T residues as a polymerase III terminator and an overhanging 
XbaI site were substituted for green fluorescent protein coding sequences in 
plasmid mU6pro (Yu et al., 2002). The construct mU6ZF14 was the most 
effective in suppressing Zhangfei protein synthesis. This was designed to target 
the Zhangfei coding sequence GGAGCTGCGGGCCGAGAAT .  It suppressed 
Zhangfei protein expression, as determined in immunoblots, by over 80% and 
completely suppressed the ability of Zhangfei to inhibit the ability of Luman to 
activate a UPRE-containing promoter. Control siRNA, RAD9 coding sequences, 
cloned in pmU6pro had no effect on Zhangfei expression. 
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3.4 Results 
 
3.4.1 Brn3a requires nuclear HCF for efficient activation of the trkA 
promoter.   
Luciano and Wilson (Luciano and Wilson, 2003) identified almost fifty 
viral and cellular proteins that posses the D/EHxY HBM. The proteins with HBM 
included Brn3a (Fig 3.1). To determine if Brn3a requires HCF for activity, we 
exploited the natural ability of ER-anchored full-length Luman to sequester HCF 
in the cytoplasm (Misra et al., 2005) as a means of depleting cells of nuclear 
HCF. Briefly, we used a mutant of full-length Luman (Lu N160G), which does 
not bind Luman response elements in promoters and is therefore 
transcriptionally inactive. This mutant, however, retains HCF in the endoplasmic 
reticulum (ER) and has the ability to severely inhibit the activity of transcription 
factors that require HCF while having no effect on factors that are HCF-
independent (Misra et al., 2005). We compared the activity of Brn3a in the 
presence of another mutant, Luman DHTY78AGTA. This mutant has an altered 
HBM and does not sequester HCF. In cells expressing this mutant most of the 
HCF is nuclear. We cotransfected cells with a plasmid expressing Brn3a and 
ptrkA1043, a CAT reporter plasmid with 1043 bp of sequence that lies upstream 
from the start of transcription of the human trkA gene, as well as plasmids 
specifying Luman DHTY78AGTA or Luman N160G. We found that while Luman 
N160G reduced levels of activation by more than 50%, Luman DHTY78AGTA 
had no effect (Fig 3.2A,B). This suggested that like other HCF-binding proteins, 
Brn3a requires HCF for efficient activation of the trkA promoter. 
 
We then determined if Brn3a was able to bind directly to HCF. We 
constructed and purified GST-linked Brn3a and synthesized biotinylated Brn3a 
and examined the ability of these proteins to bind radiolabelled HCF. As a 
positive control we used Luman, which binds HCF, and as a negative control we 
included a mutant of Luman (DHTY78AGTA) that does not bind HCF. HCF 
bound to the proteins was precipitated with glutathione beads (for GST-fusion 
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proteins) or avidin coated magnetic beads (biotinylated proteins). In both binding 
assays Brn3a did not appear to bind HCF (Fig. 3.2C). This suggests that 
although Brn3a requires HCF for activating the trkA promoter, the in vitro 
synthesized proteins do not form dimers that are stable enough to be recovered 
in “pull-down” assays. 
 
3.4.2 Zhangfei suppresses the ability of Brn3a to activate the trkA 
promoter in non-neuronal cells.  
Since Zhangfei can suppress the activity of at least two other HCF-
binding transcription factors Luman and VP16 (Misra et al., 2003, Misra et al., 
2005) we examined the ability of Brn3a to activate the 190 bp trkA minimal 
promoter (ptrkA+190) in the presence of increasing amounts of a plasmid 
specifying Zhangfei. We performed these experiments in non-neuronal Vero 
cells that do not express Brn3a or other neuronal factors to examine the 
interactions of Brn3a and Zhangfei without the confounding effects of other 
neuronal factors. Figure 3.3A shows that Zhangfei suppressed the activity of 
Brn3a in a dose dependent manner.  
 
To determine if Zhangfei was directly responsible for the suppression, we 
examined the ability of Zhangfei to suppress Brn3a in the presence or absence 
of a plasmid specifying siRNA against Zhangfei. This plasmid completely 
abrogates the ability of Zhangfei to suppress Luman, while a plasmid expressing 
siRNA against Rad9, a non-specific siRNA, has no effect (results not shown). 
These siRNAs had a very similar effect on the ability of Zhangfei to suppress the 
activity of Brn3a (Fig 3.3B). In the presence of siRNA Zhangfei, the effect of 
Zhangfei on Brn3a was eliminated. The combination of Brn3a and Zhangfei and 
siRNA Zhangfei activated the promoter to a greater extent than Brn3a alone. 
Real time PCR of the transcripts involved revealed that Vero cells express 
relative amount of endogenous Zhangfei transcripts. The effect of the siRNA 
Zhangfei not only abrogated ectopic Zhangfei but also endogenous resulting in 
a higher activation of the trkA promoter by Brn3a. These results are consistent 
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with our observations on the effects of Zhangfei on the other HCF-binding 
proteins, VP16 and Luman (Misra et al., 2003, Misra et al., 2005). 
 
To determimine if HCF binding by Zhangfei was required for Brn3a 
suppression, we compared the ability of Zhangfei or its HBM domain mutant (ZF 
Y224A), which does not bind HCF, to suppress Brn3a activation. In contrast to 
Zhangfei, its HBM mutant did not suppress Brn3a activation of either ptrkA1043 
(Fig 3.3C) or the shorter promoter construct (ptrkA+190, data not shown). 
 
3.4.3 The effect of Zhangfei is cell-type and promoter specific.   
We next examined the effect of Zhangfei on Brn3a in rat 
pheochromocytoma cells (PC12) treated with NGF. When PC12 cells are 
treated with NGF, they differentiate into neuron-like cells which have used 
extensively as surrogates for neurons in various studies on neuronal function 
and HSV-1 latency (Wilcox and Johnson, 1987, Wilcox and Johnson, 1988, 
Wilcox et al., 1990, Smith et al., 1992, Colgin et al., 2001). NGF-treated cells 
were transfected with ptrkA+190 and plasmids specifying either Brn3a, Zhangfei 
or a combination of the plasmids. Figure 3.4A shows that in contrast to Vero 
cells (Fig 3.4B, also see Fig 3.3), in PC12 cells Zhangfei did not suppress the 
ability of Brn3a to activate the minimal trkA promoter. Zhangfei, in PC12 cells, in 
contrast to the effects in Vero cells, activated the trkA promoter even in the 
absence of Brn3a.  
 
Our results suggested that the effect of Zhangfei on the trkA promoter 
was cell-type specific. To determine if the effect of Zhangfei was promoter and 
target transcription factor specific as well, we examined the effect of Zhangfei on 
the ability of Luman to activate a promoter with unfolded protein response 
elements (pCAT3BATF6). For this experiment we used Luman S221Op, a 
truncated mutant of Luman that is not anchored in the ER and is constitutively 
active (Raggo et al., 2002). As reported earlier, in Vero cells Luman S221Op 
activated the unfolded protein response elements-containing promoter several 
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hundred fold and Zhangfei completed abrogated this activity (Fig 3.4D). While 
the activity of Luman S221Op was not as profound in PC12 cells (Fig 3.4C) as 
in Vero cells (Fig 3.4D), Zhangfei had a suppressive effect (Fig 3.4C).  
 
The ability of Zhangfei to activate the trkA promoter (Fig 3.4A) in PC12 
was surprising since it does not do so in Vero cells. To determine if HCF is 
required for Zhangfei to activate trkA, we examined Zhangfei Y224A (Fig 3.4E) 
and discovered that the mutant was as effective in activating the minimal trkA 
promoter as the wild-type protein. This suggests that while Zhangfei can 
activate the trkA promoter in PC12 cells, it does not require HCF to do so. 
 
3.4.4 Zhangfei activates endogenous expression of trkA in PC12 cells. 
We have previously shown (Valderrrama and Misra, submitted, Chapter 2 
in this thesis) that not only does Brn3a activate the trkA promoter, expression of 
exogenous Brn3a in NGF-treated PC12 cells and in medulloblastoma cells 
leads to an increase in endogenous trkA transcripts. To determine if Zhangfei, 
like Brn3a, could  enhance endogenous trkA expression in NGF-differentiated 
PC12 cells, we transfected these cells with plasmids expressing Brn3a and 
Zhangfei, either alone or in combination. When compared to trkA transcript 
levels in untransfected PC12 cells, both Brn3a and Zhangfei enhanced trkA 
RNA levels between twenty and thirty fold (Fig 3.5). While Brn3a and Zhangfei 
did not appear to act synergistically, cells expressing both proteins had 
significantly higher levels of transcripts than either of the two proteins on their 
own. 
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3.5 Discussion 
 
Evidence from cultured neuronal cells as well as experimental animal 
models for HSV-1 latency and reactivation suggest an important role for NGF-
trkA signaling in the establishment and maintenance of viral latency (Wilcox and 
Johnson, 1988, Laycock et al., 1994, Hill et al., 1997, Kriesel, 1999). Recent 
data showing that neuronal cell-death caused by pseudorabies virus, which is 
closely related to HSV-1, is modulated by Brn3a, a transcription factor known to 
activate trkA expression, support these observations (Geenen et al., 2007).  In 
addition, HCF is critical for the initiation of the replicative cycle of HSV-1 and 
other alphaherpesviruses such as varicella-zoster virus and pseudorabies virus 
(Kristie et al., 1999, Khurana and Kristie, 2004, Narayanan et al., 2005). The 
recent observation that Brn3a possesses a HBM and could potentially require 
HCF for activity prompted us to investigate a possible link between Brn3a, trkA, 
NGF signaling, HCF and HSV-1 latency and reactivation. Based on our previous 
observations that Zhangfei has a suppressive effect on Luman (Misra et al., 
2005) and VP16 (Akhova et al., 2005), two other HCF-binding proteins influence 
HSV-1 gene expression, we hypothesized that Zhangfei would also suppress 
the ability of Brn3a to activate the expression of trkA and that this would have an 
impact on NGF-trkA signaling and, consequently on HSV-1 reactivation from 
latency. Our results showed that Zhangfei did not suppress the ability of Brn3a 
to activate the trkA promoter, and in contrary to our expectations induced the 
expression of trkA in the absence of Brn3a. 
 
We studied whether Brn3a requires HCF for its transcription activation 
function and if so, if this required direct interaction between the proteins. We 
found (Fig 3.2A), that Brn3a required HCF for transcription activation of the trkA 
promoter. However, Brn3a did not bind to HCF in vitro (Fig 3.2C). These results 
suggest that either Brn3a requires conformational changes to bind to HCF or 
HCF dependent activation requires the presence of other proteins found in the 
cellular environment. Brn3a dependency on HCF for the trans-activation of trkA 
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in non-neuronal cells suggests that it was possible that Zhangfei could regulate 
Brn3a’s function.  As with Luman and VP16, Zhangfei suppressed Brn3a 
transactivation of trkA in an HCF dependant manner in Vero cells.  In contrast, 
in PC12 cells, a sympathetic-like neuronal model, Zhangfei had no repressive 
effects on Brn3a trans-activation function.  Instead, Zhangfei activated the trkA 
minimal promoter (ptrkA+190) and increased trkA endogenous transcription 
without the requirement to bind to HCF.  
 
Previous studies (Akhova et al., 2005, Misra et al., 2005) and the results 
described here suggest that Zhangfei, which does not appear to bind known 
response elements for b-Zip transcription factors on its own, can either suppress 
or activate other factors. Zhangfei is one of four viral and human b-Zip factors 
that lack an asparagine residue in their basic domain. In other b-Zip factors this 
residue has been shown to be critical for binding to DNA response elements. 
The other factors that lack the asparagine residue are CCAAT/enhancer binding 
protein homologous protein (CHOP) (Ubeda et al., 1996, Ubeda et al., 1999), 
the human T-cell leukemia virus b-Zip factor (HBZ) (Gaudray et al., 2002) and 
the Kaposi sarcoma herpesvirus b-Zip protein (K-Bzip) (Izumiya et al., 2003a, 
Izumiya et al., 2003b, Liao et al., 2003). CHOP has gene activating as well as 
suppressing roles depending on its dimmerization partner and the nature of the 
cell expressing the proteins. As a dimmer of the b-Zip factors C/EBPα and β, 
CHOP blocks conversion of 3T3L1 cells to adipocytes (Batchvarova et al., 1995) 
and by suppressing osteocalcin gene transcription in osteoblasts prevents 
osteoblast differentiation (Shirakawa et al., 2006). In contrast, as a partner of 
C/EBPβ in some cells CHOP activates the expression of carbonic anhydrase 
(Sok et al., 1999). CHOP also acts as a positive regulator of gene expression in 
association witn non-C/EBP proteins such as ATF3  (Chen et al., 1996), JunD, 
c-Jun and c-Fos (Ubeda et al., 1999, Ubeda and  Habener, 2003). 
 
Some of the functions of Zhangfei, such as the suppressive effects on 
Luman and VP16 and the effect on Brn3a in non-neuronal cells, are dependent 
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on binding HCF. A mutant of Zhangfei that does not bind HCF is inefficient in 
this role. In contrast, the effect of Zhangfei on the activation of trkA in neuronal 
cells is independent of HCF. Based on these observations we propose a 
hypothetical role for Zhangfei in the establishment of HSV-1 latency as well as 
its reactivation from this state (Fig 3.6). 
 
In unstressed neurons the normal function of Zhangfei is to activate trkA 
expression. Drawing parallels with CHOP, Zhangfei probably accomplishes this 
as a partner of another b-Zip protein such as ATF4 (17). trkA expression in 
these cells promotes NGF-trkA signaling. In unstressed neurons HCF is held in 
the cytoplasm (Kristie et al., 1999), possibly in association with ER-anchored 
Luman (Lu and Misra, 2000a). Since some Luman is constitutively released 
from the ER and untimely gene activation by Luman might be detrimental to the 
cell (Raggo et al., 2002) the role of Zhangfei is to suppress Luman’s activity in 
an HCF-dependant manner. Zhangfei also, again in an HCF-dependant manner, 
suppresses the VP16-induced expression of viral IE genes in herpes simplex 
virions delivered to the neuronal cell body, thereby promoting the establishment 
of latency. The suppression of Luman, which can also activate IE genes, aids in 
this. 
 
In response to stress we hypothesize that two simultaneous events 
occur. The expression of Zhangfei ceases, leading to decrease in trkA and, 
consequently, NGF-trkA signaling. This primes the neuron for HSV-1 
reactivation (Wilcox and Johnson, 1988, Wilcox et al., 1990, Block et al., 1994, 
Laycock et al., 1994, Hill et al., 1997, Jordan et al., 1998). Stress also increases 
the release of Luman and HCF from the ER and their translocation to the 
nucleus where they further facilitate reactivation by activating the expression of 
IE genes. 
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Figure 3.1. Some proteins with HCF binding motifs. The location of the first 
amino acid of the motif in the proteins is indicated as are their accession 
numbers. The consensus Host Cell Factor binding motif (HBM) is shown (where 
D=aspartic acid, E=glutamic acid, H=histadine, x=any amino acid and 
Y=tyrosine) All the proteins listed with the exception of Brn3a have been shown 
to bind HCF and require it for activity. 
Protein   amino acid   HBM         Accession
number number
HSV-VP16 362             EHAY P06492
Luman 78 DHTY AAB69652
Zhangfei 221 DHDY Q9NS37
Krox20 162 DHLY P11161
E2F4 389 DHDY          Q16254
Brn3a 19 EHKY Q01851
Consensus D/EHxY
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Figure 3.2. Brn3a requires HCF for efficient activation of the TrkA 
promoter. A) Brn3a requirement for HCF was assessed by co-expressing 
Brn3a in Vero cells with an ER-associated mutant of Luman (Lu N160G) that 
possesses no transcriptional activity alone but retains HCF in the cytoplasm. As 
a control Brn3a was either expressed alone or with an ER-associated mutant of 
Luman with an altered HBM (Lu DHTY:AGTA), which does not retain HCF in the 
cytoplasm. Neither Lu N160G nor Lu DHTY:AGTA activate the trkA promoter. 
All transfections contained the reporter plasmid ptrkA1043. B) Immunoblot of 
cell lysates in ‘A’ screened for Brn3a, Luman or beta-actin C) In vitro binding of 
radioactive (35S) HCF to Brn3a as assessed by GST or biotin-avidin 
precipitation. Lane 1 - input HCF alone, Lane 2 – HCF + GST  or biotinylated 
Luman, Lane 3 – HCF + GST or biotinylated Luman (DHTY78AGTA) (mutated 
HBM), Lane 4 – HCF + GST or biotinylated Brn3a.  
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Figure 3.3. Zhangfei suppresses the ability of Brn3a to activate the TrkA 
promoter in non-neuronal cells. A) Vero cells were transfected with the trkA 
promoter reporter ptrkA+190, a plasmid that specifies Brn3a and varying 
amounts (0-3 µg) of a plasmid that expresses Zhangfei. The first bar 
(ptrkA+190) represents CAT activity of the reporter without Brn3a and is 
regarded as 1. Total DNA in each reaction was adjusted to 6 µg with the empty 
vector pcDNA3. B) siRNA against Zhangfei inhibits its suppressive effect on 
Brn3a. Vero cells were transfected with the trkA reporter and pcDNA, a plasmid 
specifying Brn3a, and a Zhangfei expressing plasmid. One batch of cells also 
received a plasmid expressing siRNA ZF, the other a plasmid expressing an 
irrelevant siRNA (Rad9). C) Zhangfei must bind HCF to suppress Brn3a activity. 
Vero cells were transfected with a trkA promoter reporter (ptrkA1043), a plasmid 
expressing Brn3a and varying amounts of a plasmid expressing either Zhangfei 
or a mutant with a HBM that does not bind HCF (ZFY224A). CAT activity was 
measured 48 hr after transfection. 
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Figure 3.4. The effect of Zhangfei is dependant on the promoter and cell-
type. A) PC12 cells were transfected with the trkA reporter, ptrkA+190, and 
pcDNA3, or plasmids expressing Brn3a alone, Zhangfei alone or both Brn3a 
and Zhangfei. After overnight incubation cells were treated with NGF and 
assayed for CAT 48 hr later.  B) Vero cells were transfected with the trkA 
reporter and pcDNA, a plasmid specifying Brn3a, and a Zhangfei expressing 
plasmid. C) PC12 cells were transfected with a reporter with Luman-responsive 
UPRE binding sites  (pCATB3-ATF6) and pcDNA3, or plasmids expressing 
Luman alone, Zhangfei alone or both Luman and Zhangfei. After overnight 
incubation cells were treated with NGF and assayed for CAT 48 hr later. D) 
Vero cells were transfected with pCATB3-ATF6 and pcDNA, a plasmid 
specifying Luman , and a Zhangfei expressing plasmid.  E) Cells were 
transfected with ptrkA+190, and pcDNA3, or plasmids expressing Zhangfei or 
and mutant ZhangfeiY224A (mutated HBM). 
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Figure 3.5. Brn3a and Zhangfei activate endogenous TrkA in PC12 cells. 
Cells were transfected with plasmids expressing pcDNA, Brn3a, 
Brn3a+Zhangfei or Zhangfei. Forty-eight hr after NGF treatment RNA from the 
cells was assayed for trkA transcripts using quantitative real-time PCR. Values 
are normalized to GAPDH transcripts in each sample and the value for the 
sample with no Brn3a or Zhangfei was designated as 1. Bars are standard 
errors of means. 
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Figure 3.6. Model for the role of Zhangfei in unstressed and stressed 
neurons. N=NGF, trkA=NGF receptor tyrosine kinase, H=HCF, Lu=Luman, 
B=Brn3a. In unstressed neurons Luman and associated HCF is anchored in the 
ER. Zhangfei, in an HCF-independent manner, along with Brn3a activates the 
expression of trkA. trkA enables NGF-mediated signaling which create 
suppresses HSV-1 reactivation in latently infected neurons. Zhangfei also 
suppresses HSV-1 lytic cycle by suppressing VP16 associated with incoming 
viral nucleocapsids with associated VP16 (tegument). Zhangfei also suppresses 
any Luman that might be released from the ER thereby further blocking the 
HSV-1 lytic cycle. In response to stress the expression of Zhangfei is 
suppressed thereby decreasing trkA expression and, consequently, suppressing 
NGF signaling and triggering HSV-1 reactivation. A reduction in Zhangfei also 
allows proteolytically activated Luman to induce the expression of IE genes and 
hence the HSV-1 lytic cycle. 
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4.1 Abstract 
 
Herpes simplex viruses (HSV) establish latent infections in the sensory 
neurons of their hosts and are maintained in this state by little understood 
mechanisms that, at least in part, are regulated by signalling through nerve 
growth factor (NGF) and its receptor tyrosine kinase, trkA. NGF-trkA interactions 
influence other neuronal functions as well, including the correct spatial and 
temporal development of sensory neurons during embryogenesis, the survival of 
sensory neurons and the differentiation and apoptosis of neuronal tumors. 
Zhangfei is a transcriptional factor that is expressed in differentiated neurons 
and is thought to influence HSV replication and latency. Zhangfei, like the HSV 
transactivator VP16, binds the ubiquitous nuclear protein host cell factor (HCF). 
Zhangfei inhibits the ability of VP16 to initiate HSV replication and may play a 
role in the establishment of viral latency. Since we were unable to detect 
Zhangfei in neuronal tumor cells we hypothesized that ectopic expression of the 
protein in medulloblastoma cells may induce differentiation. We show that in 
ONS-76 medulloblastoma cells resveratrol, an inducer of apoptosis and 
differentiation, increased the expression of Zhangfei and trkA as well as Early 
Growth Response Gene 1 (Egr1), a gene normally activated by NGF-trkA 
signalling. ONS-76 cells stopped growing soon after treatment with resveratrol. 
A portion of the cells underwent apoptosis while others extended long 
interconnecting processes and remained viable for more than thirty days. While 
the induction of Zhangfei in resveratrol-treated cells was modest albeit 
consistent, the infection of actively growing medulloblastoma cells with an 
adenovirus vector expressing Zhangfei mimicked the effects of resveratrol. 
Zhangfei activated the expression of trkA and Egr1 and caused these cells to 
display markers of apoptosis. Binding of HCF by Zhangfei did not appear to be 
required for this effect as a mutant of Zhangfei incapable of binding HCF also 
induced the expression of trkA and Egr1.  UW228, another medulloblastoma 
cell-line was also susceptible to the suppressive effects of resveratrol and 
Zhangfei. In contrast, while resveratrol suppressed the growth of human diploid 
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fibroblasts (MRC5), Zhangfei did not appear to have an effect on these cells for 
three days after infection. 
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4.2 Introduction 
 
The tropomyosin related kinase (trkA), is the main high-affinity receptor 
for nerve growth factor (NGF) (Parada et al., 1992, Huang and Reichardt, 2003). 
In the developing mouse embryo, trkA is expressed in neural crest derived 
neurons destined to become sensory neurons with cell bodies in trigeminal and 
dorsal root ganglia (Martin-Zanca et al., 1990, Crowley et al., 1994). It is also 
present in sympathetic neurons. trkA-NGF interactions in neuronal cells control 
cell fate, differentiation, survival, proliferation, axonal growth and target 
innervation (Bibel and Barde, 2000, Huang and Reichardt, 2003). The 
expression of trkA in pain-sensing nociceptive neurons and some sympathetic 
neurons continues after birth and signalling through them is thought to be 
important for the maintenance of differentiated phenotype and survival of these 
cells. Consistent with this is the ability of NGF to reverse injury-induced 
alterations in sensory neuron phenotype (Verge et al., 1992, Verge et al., 1995) 
and its ability to mitigate aspects of diabetic neuropathy (Sasaki et al., 2004, 
Walwyn et al., 2006). trkA expressing neurons are also the site of herpes 
simplex virus (HSV) latency and deprivation of cells harbouring latent HSV of 
NGF triggers reactivation of virus (Wilcox et al., 1990, Laycock et al., 1994, Hill 
et al., 1997, Kriesel, 1999).  
 
Beyond the role of NGF-trkA signalling in maintaining sensory neurons, 
this pathway may also be important in regulating uncontrolled cell division in 
neuroblastomas and medulloblastomas, two childhood neuronal cancers. Thus 
the presence of trkA in neuroblastomas and medulloblastomas correlates with 
increased rates of apoptosis in tumor cells and favourable outcomes in patients 
(Tajima et al., 1998, Eberhart et al., 2001, Ohta et al., 2006). In addition, 
restoration of trkA expression in tumor cells devoid of trkA makes them 
responsive to NGF and leads to their differentiation or apoptosis (Muragaki et 
al., 1997, Chou et al., 2000, Eggert et al., 2000). 
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Herpes simplex virus type 1 (HSV-1) uses two complimentary strategies 
to avoid immune surveillance and to maintain itself in its host. Infection begins 
with virus replication and the lysis of infected epithelial cells. During lytic 
replication, the virus infects sensory nerves and establishes a latent infection in 
neuronal nuclei located in sensory ganglia (reviewed in (Efstathiou and Preston, 
2005)). The virus is thought to be almost completely quiescent during latent 
infection. Only one viral transcript and no readily detectible viral proteins are 
expressed.  
 
A variety of physiological and psychological stressors reactivate the 
latent viral genome to reenter the lytic phase.  Following reactivation, the virus 
replicates in neurons and travels down the axons of sensory neurons to 
replicate again in epithelial cells causing a recrudescent lesion (reviewed in 
(Roizman, 2001)). However, the molecular mechanisms responsible for 
reactivation are not well understood. Neurons latently infected in culture, and 
explanted ganglia from mice with latent HSV, require NGF for the maintenance 
of the latent state and depletion of NGF induces the virus to enter the productive 
cycle (Wilcox and Johnson, 1987, Wilcox and Johnson, 1988, Wilcox et al., 
1990). Similarly, increase in intracellular cAMP by the treatment of latently 
infected neurons with forskolin leads to reactivation (Smith et al., 1992). Colgin 
and others (Colgin et al., 2001) have reported that levels of inducible cAMP 
Early Repressor, an inhibitory transcriptional regulator of the cAMP response 
element (CRE) binding family of proteins, are elevated in response to both NGF 
depletion and elevation in intracellular levels of cAMP. NGF depletion and 
increase in cAMP levels may also derepress the expression of productive cycle 
genes. The withdrawal of NGF as well as treatment with trichostatin-A, a drug 
that inhibits histone deacetylases, activates lytic cycle genes (Arthur et al., 
2001, Danaher et al., 2005). Since trichostatin-A treatment of neurons induces 
cellular factors that block NGF signaling (Sano and Kitajima, 1996) this 
suggests a role for histone remodeling in reactivation. Stimulation of the 
vanilloid/capsaicin receptor (VR-1), which is a calcium channel, by capsaicin, 
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heat or stimulators of PKC or PKA, leads to reactivation in a cell culture model 
(Hunsperger and Wilcox, 2003a). This implicates VR-1 as a common pathway 
for several of the reactivating stimuli. The induction of caspase 3 in latently 
infected neurons also causes reactivation (Hunsperger and Wilcox, 2003b).  
 
During  lytic infection of epithelial cells by HSV-1 the expression of viral 
genes is temporally regulated and the approximately 80 viral genes involved can 
be described as Immediate Early (IE), Early (E) or Late (L) depending upon the 
order of their expression. Initiation of the transcription of the IE genes is induced 
by the assembly of a multi-protein complex made up of the virion protein VP16 
and the two cellular proteins: Oct-1 and host cellular factor (HCF) (reviewed in 
(Wysocka and Herr, 2003)). 
 
HCF is a ubiquitously expressed chromatin-associated protein. The 
mature form of HCF is derived from a 2035 amino acid precursor which is 
processed by internal proteolytical cleavage to amino and carboxyl terminal 
portions that are held together by no-covalent interactions (Wilson et al., 1993, 
Kristie et al., 1995). Although HCF was initially discovered as a component of 
the VP16-induced transcriptional complex it is important for many cellular 
processes including cell-cycle progression and cytokinesis (Julien and Herr, 
2003), chromatin structure modification and RNA splicing (Ajuh et al., 2002, 
Wysocka et al., 2003). In addition to these cellular roles, HCF participates in the 
regulation of the IE gene expression of HSV-1, varicella-zoster virus (Narayanan 
et al., 2005) and possibly that of other alpha herpesviruses as well. VP16 binds 
to the amino-terminal component of HCF, which possesses a -propeller-like 
structure formed by six Kelch repeats (Wilson et al., 1997, Hughes et al., 1999).  
 
Several cellular proteins, which like VP16, interact with the amino-
terminus of HCF share the HCF, binding motif (HBM) D/EHxY. These include, 
E2F4 (Luciano and Wilson, 2003, Knez et al., 2006), Krox20 (Luciano and 
Wilson, 2003), Luman/LZIP/CREB3 (Lu et al., 1997, Lu et al., 1998, Lu and 
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Misra, 2000a) and Zhangfei (Lu and Misra, 2000b). The motif is present in other 
proteins as well, but HCF binding by these proteins has not been examined 
(Luciano and Wilson, 2003). 
 
Zhangfei has the characteristics of a basic leucine-zipper (b-Zip) 
containing protein. However, unlike other b-Zip proteins Zhangfei does not bind 
any of the known cognate sequences for b-Zip proteins nor does it activate 
promoters containing these sequences (Lu and Misra, 2000b, Hogan et al., 
2006). Zhangfei has a profoundly repressive effect upon HCF-dependant 
transcription activation by Luman (Misra et al., 2005) and VP16 (Akhova et al., 
2005). HCF binding by both Zhangfei and its targets is required for efficient 
suppression by Zhangfei. Interestingly, while Zhangfei and Luman have 
incompatible b-Zip domains and do not interact directly, Zhangfei does have the 
capacity to dimerize with other factors such as Xbp1, and ATF4 through their b-
Zip domains (Newman and Keating, 2003). The effect of these interactions can 
lead to suppression of gene expression, with Xbp1 (Chauhan et al manuscript 
submitted) or lead to gene activation, with ATF4 (Hogan et al., 2006). 
 
Since Zhangfei was not detected in neuronal tumor cells we hypothesised that 
ectopic expression of the protein in medulloblastoma cells may induce them to 
differentiate. We show that in medulloblastoma cells resveratrol, an inducer of 
apoptosis and differentiation in these cells, increased the expression of Zhangfei 
as well as trkA and Early Growth Response Gene 1 (Egr1), a gene normally 
activated by NGF-trkA signalling. Medulloblastoma cells stopped growing soon 
after treatment with resveratrol. A portion of the cells underwent apoptosis while 
others extended long processes and remained viable for more than thirty days. 
While the induction of Zhangfei in resveratrol-treated cells was modest, albeit 
consistent, the ectopic expression Zhangfei in actively growing medulloblastoma 
cells mimicked the effects of resveratrol. Zhangfei activated the expression of 
trkA and EgR1 and caused these cells to display markers of apoptosis. Binding 
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of HCF by Zhangfei did not appear to be required for this effect as a mutant 
incapable of binding HCF also induced the expression of trkA and Egr1.  
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4.3 Materials and Methods 
 
4.3.1 Cell Culture  
Human medulloblastoma cells (ONS-76, (Yamada et al., 1989) and 
UW228 (Keles et al., 1995)) were obtained from Michael Taylor (University of 
Toronto) and grown in Dulbecco’s modified Eagle’s medium (D-MEM) with 10% 
foetal bovine serum (FBS) and 1% penicillin-streptomycin. For some 
experiments medulloblastoma cells were plated at a density of 2 X 104 cells per 
cm2. After incubating overnight the medium was replaced with D-MEM 
containing 1% FBS and antibiotics and 100µM resveratrol (Sigma). Stock 
solutions of resveratrol were made up in dimethyl sulphoxide (DMSO) DMSO 
and control cultures received an equivalent amount of DMSO. For long term-
cultures of ONS-76 cells in resveratrol half the medium was replaced every 
other day. Rat pheochromocytoma (PC12) cells (provided by D. D. Mousseau, 
University of Saskatchewan) were maintained in Complete Medium containing  
RPMI 1640 supplemented  with 10% horse heat  inactivated serum, 5% of  
foetal bovine serum, 2 mM glutamine and 1% penicillin-streptomycin. PC12 cells 
were cultured at a density of 2 x 106 in 6 well collagen coated plates.  To 
differentiate PC12 cells they were “fasted” in low serum media, RPMI 1640 
supplemented with 1% foetal bovine serum and 1% penicillin-streptomycin, 
overnight before treatment with  nerve growth factor  (50 ng/ml). Human diploid 
fibroblasts, MRC-5 cells (American Type Tissue Culture Collection), were grown 
in D-MEM containing 10% FBS and antibiotics 
 
To determine the growth rate cells  were plated at a density of 2 X 104 
cells per cm2 in wells of six-well culture dishes. At daily intervals cells in the 
culture supernatant as well as adherent cells recovered by typsinization and 
collected in phosphate buffered saline containing 10% FBS were pelleted and 
resuspended in 0.5 ml PBS containing 0.08% trypan blue. Trypan blue 
containing and excluding cells were counted separately in a haemocytometer in 
triplicate samples. 
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4.3.2 Immunoblots  
Proteins in cell lysates were separated by SDS-polyacrylamide gel 
electrophoresis and probed by immunoblotting as described earlier. Rabbit 
polyclonal antibodies against Erk1/2 (Map kinase p44/42) that detect total 
Erk1/2 or phosphorylated Erk1/2 (Cederlane/Cell Signaling, Hornby, Ontario, 
Canada) specific for human Erk1 wee used to probe the immunoblots. 
 
4.3.3 Adenovirus vectors expressing Zhangfei  
The construction, growth and purification of adenovirus vectors (Adeno-X 
Expression System, Clontech) expressing Zhangfei or beta-galactosidase has 
been described (Misra et al., 2005). ONS-76 cells in 6 well plates were infected 
at a multiplicity of infection of 10 plaque-forming units of Adeno-Zhangfei or 
Adeno-LacZ per cell in 0.2 ml of OptiMEM, or were mock-infected. After 1 hr at 
37oC, 2 ml of medium containing 10% serum were added. The next day the 
medium was replaced with medium containing 1% serum. Cells were 
photographed in a phase-contrast microscope or harvested for RNA extraction 
48 hr later.   
 
4.3.4 RNA preparation and Real time PCR (QPCR) analysis.  
Total RNA was extracted from cells in 6 well tissue culture plates using 
Trizol (Invitrogen) as suggested by the manufacturer and dissolved in 20 µl of 
DEPC-treated water. Next, 5 µg of total RNA was used for first strand cDNA 
synthesis using Superscript II reverse transcriptase (Invitrogen). To detect and 
quantitate trkA and other transcripts we used Brilliant SYBR Green QPCR 
Master Mix (Stratagene). Samples were amplified in an Mx3005XP QPCR 
thermocycler (Stratagene) using the following thermocycle conditions: one cycle  
at 95 °C for 10 min, 40 cycles of 95°C for 30 s, 60°C for  1 min and 72°C for  1 
min. Data were analyzed using the thermocycler-associated software. For each 
sample cycle threshold values for the assayed transcripts (trkA, NGF, Zhangfei 
and Egr1) were normalized for total input RNA concentrations using cycle 
threshold values for transcripts for the “normalizer” house-keeping gene, 
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GAPDH. The normalized values in each experiment were compared to a 
“calibrator” sample to determine the relative increase in the amount of the 
transcript. Results were analyzed for significant differences using the Student T-
TEST. The primer sets for transcript amplification were used at a final 
concentration of 40 nM. The sequences of the primers were as follows: 
NGF-F: 5’ – caggactcacaggagcaagc; NGF-R: 5’ – gccttcctgctgagcacaca; trkAcd-
F: 5’ - gagggcaaaggctctggactcca-3’; trkAcd-R:  5’- agactccgaagcgcacgatg-3’: 
ZF-F:  5’- ctgaccacctccctcttcag-3’; ZF-R: 5’- cagaactccaccgacacctt-3’; Gapdh-F: 
5’-gcctcctgcaccaccaactg; Gapdh-R: 5’- gggccatccacagtcttctgg; Egr1-F:  5’ - 
gcacccaccagtggcaac-3’ and Egr1-R:  5’- ‘gggatcatgggaacctgg-3. Following 
amplification, the melting curves for the products were generated to ensure that 
the product represented a homogenous species. In addition, the PCR products 
were analyzed by electrophoresis to ensure that a product of the predicted size 
had been generated. The expected sizes of amplified products were 300 bp for 
Egr1, 150 bp for Zhangfei, 300 bp for trkA ,130 bp for GAPDH and 300 bp for 
NGF. 
 
4.3.5 Apoptotic cells   
To estimate the number of apoptotic cells in a culture the proportion of 
cells expressing active caspase 3 or external phosphatidylserine were 
determined using the Active Caspase-3 PE MAb Apoptosis kit and the Annexin 
V-FITC Apoptosis Detection Kit. Both kits were purchased from BD Biosciences 
Pharmingen. The techniques used were as suggested by the manufacturer. 
Fluorescent cells were analyzed by flow cytometry on a Beckman-Coulter Epics 
XL flow-cytometer and analyzed using EXPO32 software. Figures were 
generated using Flow Jo 8.1. 
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4.4 Results 
 
Resveratrol or 3,5,4’-trihydroxy-trans-stilbene, is a phytoalexin found in 
many plant products including red wine. Resveratrol results in differentiation and 
apoptosis of neuroblastomas and medulloblastomas (Tredici et al., 1999, 
Nicolini et al., 2003, Wang et al., 2003, Chen et al., 2004, Zhang et al., 2006). 
ONS-76 is a human medulloblastoma cell line derived from a cerebellar tumor in 
a 2-year-old girl (Yamada et al., 1989). The cells exhibit the characteristics of 
both neuronal and glial cells (Park et al., 1998). We found that treating ONS-76 
medulloblastoma cells with 100 µM resveratrol caused an immediate cessation 
of their growth with no increase in viable cells in the 24 hr after treatment (Fig 
1). Cultures after 24 hours of resveratrol treatment contained few trypan blue 
staining cells suggesting that the lack of increase in cell numbers was not due to 
cell death. While there was a gradual decrease in cell numbers over a period of 
time most cells became elongated with processes that appeared to reach out to 
other cells (Fig 4.1C). The cells remained healthy up until at least 30 days after 
which they were fixed in methanol. 
 
4.4.1 Differentiated medulloblastoma cells show trkA-mediated signalling. 
Since the restoration of trkA signalling in medulloblastomas leads to their 
apoptosis or differentiation, we questioned whether the reverse was true: could 
the induced differentiation of these cells lead to trkA expression and if so, did 
Zhangfei played a role in this? Medulloblastoma cells were induced to 
differentiate with resveratrol (Zhang et al., 2006). Zhangfei, trkA, NGF, Egr1 and 
GAPDH transcript levels in resveratrol-differentiated cells and growing cells 
(control cells were treated with an equivalent amount of DMSO, the solvent for 
resveratrol) were measured using qRT-PCR. Egr1 is one of the genes activated 
as a result of NGF-trkA signalling (Harada et al., 2001). 
 
Differentiation of ONS-76 cells was accompanied by a modest but significant 
increase in Zhangfei (1.4 fold), trkA (4 fold), Egr1 (7 fold) and NGF (11 fold) 
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transcripts (Fig 4.2A).  These results suggested that resveratrol induces NGF-
trkA signalling in ONS-76 cells. trkA signalling requires its ligand NGF. Although 
we did not add NGF to the cultures, the qRT-PCR results indicated that ONS-76 
cells express endogenous NGF and that its level increases when the cells are 
treated with resveratrol. To confirm that the resveratrol-treated cells contain 
NGF, thereby allowing autocrine stimulation of the induced trkA receptor, we 
examined the ability of lysates from resveratrol or DMSO-treated cells to induce 
neurite formation in rat PC12 cells. These cells can be induced to differentiate 
into sympathetic neuron-like cells if treated with NGF. One of the characteristics 
of differentiated PC12 cells is the sprouting of neurite-like processes (Fig 4.2C, 
top panel). High concentrations of lysates from ONS-76 cells were toxic for 
PC12 cells. PC12 cells treated with lysate from resveratrol-treated ONS-76 cells 
diluted 40 fold showed some neurite-like processes (Fig 4.2C, lower panel, 
arrows).  Lysates of growing ONS-76 cells also induced some neurites in PC12 
cells although these were less obvious than in cells treated with an equivalent 
concentration of lysate from resveratrol-treated ONS-76 cells (not shown). 
Concentrations of resveratrol greater than 25 µM were toxic to PC12 cells. No 
neurites were seen in PC12 cells treated with 25µM of resveratrol. 
 
4.4.2 Expression of Zhangfei in growing ONS-76 cells leads to 
suppression of growth, induction of trkA and the trkA-NGF pathway.  
There appeared to be a progressive increase in the magnitude of 
transcripts for Zhangfei, trkA and Egr1 in response to resveratrol (Fig 4.2 A).  
One interpretation of these results is that Zhangfei plays a role in the induction 
of trkA expression, which then leads to an increase in Egr1 expression. To study 
this possibility, we infected ONS-76 cells with adenovirus vectors expressing 
either Zhangfei (Ad-ZF) or the irrelevant bacterial protein, beta galactosidase 
(Ad-LacZ). Cells were also mock-infected (MI). Cells were counted at the time of 
infection and then for the next four days (Fig 4.3A). Infection with adenovirus 
expressing Lac-Z had no effect on the growth of ONS-76 cells. In contrast cells 
infected with adenovirus expressing Zhangfei stopped growing by 2 days 
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following infection. At this time (Fig 4.3D) cells infected with adeno-LacZ were 
crowded while, cells infected with adenovirus expressing Zhangfei appeared to 
have died (bright, refractory cells in Fig 4.3D) or were spread out. Many of these 
cells had long processes. When these cells were examined for Zhangfei, trkA 
and Egr1 transcripts, we found that compared to mock-infected and adeno-beta 
galactosidase expressing cells the cells infected with adeno-Zhangfei showed a 
five-fold increase in trkA transcripts and an almost thirty-fold increase in Egr1 
transcripts. As expected, adeno-ZF infected cells had 2000 fold more Zhangfei 
transcripts than MI or adeno-LacZ infected cells (not shown). These results 
suggest that in ONS-76 medulloblastoma cells the expression of Zhangfei on its 
own can lead to an enhancement of trkA signalling. 
 
4.4.3 Zhangfei does not require binding to HCF to induce trkA and Egr1 
expression  
Zhangfei binds HCF (Lu and Misra, 2000b) and a mutant with a non-
functional HBM does not suppress the activity of Luman and VP16 (Akhova et 
al., 2005, Misra et al., 2005) suggesting that at least some of the functions of 
Zhangfei require HCF. To determine if HCF binding was needed for Zhangfei to 
activate trkA and Egr1 expression, we compared the level of transcripts for 
these two genes in cells infected with adenovirus vectors expressing beta 
galactosidase, Zhangfei or Zhangfei (Y224A). The latter is a mutant in which the 
tyrosine residue in the HBM (DHDY224) has been changed to alanine (DHDA). 
Figure 4.3C shows that, if anything, Zhangfei Y224A was more effective at 
activating trkA and Egr1 than wild-type Zhangfei. This might be caused by a 
damping effect of HCF on Zhangfei which has more affinity for binding to HCF. 
 
4.4.4 Zhangfei induces the phosphorylation of Erk.  
Since the transcription of Egr1, an immediate early gene in the NGF-trkA 
pathway, is enhanced through the phosphorylation of extracellular signal-
regulated kinase (Erk1/2) (Harada et al., 2001) we examined ONS-76 cells 
treated with either DMSO or resveratrol, or cells infected with either adeno-beta 
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galactosidase or adeo-Zhangfei for Erk1/2 and phosphorylated Erk1. An 
antibody against Erk1/2 detected the p42 form of Erk1 in all four samples (Fig 
4.4, top panel). A less intense band for p44 Erk2 was also detected. Only cells 
infected with adeno-Zhangfei contained detectable phospho-Erk1 (Fig 4.4, lower 
panel). 
 
4.4.5 Resveratrol as well as Zhangfei trigger apoptosis in ONS-76 cells. 
 Since resveratrol induces some medulloblastoma cells to enter 
apoptosis (Wang et al., 2003, Zhang et al., 2006) we determined if expression of 
Zhangfei in these cells would do so as well. ONS-76 cells were treated with 
either DMSO or resveratrol or infected with either adeno-LacZ or adeno-ZF. 
Twenty-four hours following infection cells were analyzed for two markers of 
apoptosis, expression of activated caspase 3 or the detection by annexin V of 
phosphatidylserine on the surface of the plasma membrane. Resveratrol caused 
an increase in the number of apoptotic cells in the culture, 20 fold as measured 
by caspase 3 and 3 fold as determined by annexin V. Zhangfei caused a similar 
increase in apoptotic cells 11 fold as measure by caspase 3 and 4.5 fold by 
annexin V (Fig 4.5). 
 
4.4.6 Unlike resveratrol Zhangfei does not suppress the growth of diploid 
human fibroblasts.  
While resveratrol has been shown to have anti-tumor and anti-oxidant 
activity it is thought to be relatively non-toxic. One would therefore expect it to 
have no effect on the growth rate of normal cells. While it is not possible to 
examine the growth of normal neurons, we examined the effects of resveratrol 
and Zhangfei on MRC5 cells, a human diploid cell line. MRC5 cells are 
untransformed human lung fibroblasts derived from the normal lung tissue of a 
14-week-old male foetus (Jacobs et al., 1970). This cell line is considered to be 
a normal diploid human cell-line with a 46, XY karyotype occurring in over 70% 
of cells. MRC5 cells undergo senescence after 40-50 doublings. MRC5 cells 
were either treated with DMSO or resveratrol or infected with adeno-LacZ or 
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adeno-ZF. Surprisenly, resveratrol inhibited the growth of MRC5 cells as 
efficiently as it did ONS-76 cells (Fig 4.6A). In contrast, the growth rates of 
Zhangfei expressing cells (over three days) were not different from cells treated 
with DMSO or infected with adeno-LacZ, nor was microscopic morphology 
different from normal MRC5 cells. 
 
4.4.7 Resveratrol and Zhangfei inhibit the growth of another 
medulloblastoma cell-line  
To determine if resveratrol and Zhangfei affected the growth of other 
medulloblastoma cell lines we examine UW228 cells. This cell line was derived 
from a posterior fossa medulloblastoma and the cells are positive for 
neurofilaments and synaptophysin (Keles et al., 1995). As with ONS-76 cells, 
resveratrol and Zhangfei suppressed the growth of UW228 cell (Fig 4.6B) 
indicating that the effects were not restricted to one medulloblastoma cell line. 
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4.5 Discussion 
 
Zhangfei suppresses the initiation of HSV-1 gene expression in cells 
normally permissive to viral expression (Akhova et al., 2005). We have reported 
its presence in mature sensory neurons (Akhova et al., 2005), which are the site 
of HSV-1 latency, suggesting that Zhangfei may be involved in the suppression 
of viral gene expression during the establishment of HSV-1 latent infection in 
these cells. We have also detected Zhangfei in pyramidal neurons. We did not 
detect Zhangfei in actively growing cells of medulloblastoma cell lines and in 
cells in the trigeminal ganglia of the developing early mouse embryo. In these 
cells the protein was not apparent until 14 days of gestation, after which it 
increased in expression (Nazarali, personal communication). These 
observations led us to speculate that Zhangfei may be involved in the 
differentiation of neurons. In this study we examined the possibility that ectopic 
expression of Zhangfei in medulloblastoma cells induces signalling pathways 
that may lead to their differentiation. To test this hypothesis we examined ONS-
76 cells induced to undergo differentiation with resveratrol. Since 
medulloblastoma cells can also be induced to differentiate if they are made to 
express trkA, we also examined these cells for trkA, NGF and Egr1 transcripts. 
In PC12 cells treated with NGF the phosphorylation of Erk1/2 leads to the 
activation of Egr1, (Harada et al., 2001, Levkovitz and Baraban, 2002) which is 
an immediate early response gene in the NGF-trkA signalling pathway. Egr1 
then by activating p35 and CdK5 stimulates neural outgrowth and the 
withdrawal of the cells from the cell-cycle. The phosphorylation of Erk1/2 is also 
critical for differentiation of embryonic stem cells into neurons (Li et al., 2006). 
We found that transcripts for Zhangfei as well as the other genes tested were 
elevated in resveratrol differentiated cells when compared with undifferentiated 
cells (Fig 4.2). By infecting growing ONS-76 cells with an adenovirus vector 
expressing Zhangfei we showed that Zhangfei could lead to an increase in the 
expression of trkA and Egr1 (Fig 4.3). Our observation that Erk1 was 
phosphorylated in these cells (Fig 4.4) supports our hypothesis that Zhangfei is 
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a mediator of trkA-NGF signalling in these cells leading to either their 
differentiation or apoptosis. 
  
Nerve growth factor-trkA signalling is important for the development and 
differentiation of nociceptive sensory neurons and sympathetic neurons during 
development of the mouse (Martin-Zanca et al., 1990, Crowley et al., 1994, 
Bibel and Barde, 2000, Huang and Reichardt, 2003). It is also required for the 
survival and function of sensory neurons after birth and plays a role in regulating 
the development of neuronal tumors (Muragaki et al., 1997, Tajima et al., 1998, 
Chou et al., 2000, Eggert et al., 2000, Eberhart et al., 2001, Ohta et al., 2006) 
as well as in the maintenance of HSV-1 latency (Wilcox et al., 1990, Laycock et 
al., 1994, Hill et al., 1997, Kriesel, 1999). While there is information on 
transcription factors that regulate trkA expression during embryonic 
development, the mechanisms by which trkA expression in neuronal tumors is 
regulated is not known. 
 
Zhangfei suppresses the activity of other HCF-binding proteins such as 
Luman and VP16. While both Zhangfei and Luman are b-Zip proteins, they 
appear to have incompatible interacting domains (Vinson et al., 2002, Newman 
and Keating, 2003) and do not heterodimerize (Lu et al., 1997, Liang et al., 
2006). However, since both bind HCF it is possible that their interactions involve 
HCF and, perhaps, other associated proteins. VP16 is not a b-Zip protein and 
interactions between it and Zhangfei probably involve HCF as well. While 
Zhangfei and Luman do not dimerize through their b-Zip domains Zhangfei does 
interact with other proteins through their b-Zip regions. The results of these 
interactions can activate or suppress transcription of target genes. Thus, 
Zhangfei and Xbp1 (Chauhan personal communication) have a suppressive 
effect and Zhangfei as a heterodimer with ATF4 (Hogan et al., 2006) activates 
promoters containing unfolded protein response elements. Although it is not 
known whether these b-Zip-mediated interactions of Zhangfei require HCF, it is 
possible that they do not. Zhangfei may therefore, in a HCF-independent 
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manner, activate transcription in neurons by dimerizing with b-Zip proteins such 
as ATF4. 
 
Interestingly, we found that while both resveratrol and Zhangfei 
suppressed the growth of at least two medulloblastoma cell-lines they differed in 
their effects on human diploid cells considered to be relatively normal in their 
growth characteristics. While resveratrol prevented these cells from growing, 
Zhangfei had no apparent effect three days after treatment. Since we infected 
these cells with an adenovirus vector that expressed Zhangfei from the very 
active cytomegalovirus immediate early promoter they produced large amounts 
of protein. The cells did eventually die but this was probably because of toxic 
effects of large amounts of Zhangfei protein. We have yet to examine the effects 
of long-term expression of physiological levels of the protein in normal cells. 
  
In our model (Figure 4.7) for the involvement of Zhangfei in HSV latency, 
Zhangfei acts to promote HSV latency by suppressing VP16. It also acts to 
maintain latency by stimulating trkA expression and the NGF-trkA signalling 
pathway. In vitro models of HSV latency, the virus reactivates when latently 
infected cells are deprived of NGF. In animal models when sectioning of the 
trigeminal nerve interrupts NGF-trkA signalling, or when infected neurons are 
cultured with HSV permissive cells in the absence of NGF, the latent virus 
reactivates. Since NGF is produced by many cell types and is upregulated 
during inflammation (which paradoxically has been linked to reactivation) it is 
possible that reactivation is triggered not by a decrease in NGF but by a down-
regulation of trkA expression. We hypothesize that this is brought about by 
stress-related suppression or decrease in expression in neurons of Zhangfei. 
This would allow neuronal HCF-binding proteins such as Luman, which can 
activate HSV IE expression, to initiate HSV IE expression and subsequently 
viral replication. 
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Figure 4.1. Resveratrol suppresses the growth of ONS-76 
medulloblastoma cells. A) ONS-76 cells were plated in 6 well culture dishes in 
medium containing 10% FBS. After overnight incubation the cells were treated 
with either medium containing 1% FBS and 100 µM resveratrol (squares) or 
medium containing DMSO (circles). At this time and every day for the next three 
days viable (solid symbols) and trypan blue staining cells (open symbols) were 
counted in triplicate well. Bars indicate standard deviation from the mean. B) 
phase-contrast micrographs of DMSO and resveratrol-treated cells at day 1 and 
three after beginning of treatment. C) Photomicrograph of resveratrol-treated  
cells 15 days after treatment.
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Figure 4.2. Treatment with resveratrol leads to an increase in transcripts 
for Zhangfei, TrkA, Egr1 and NGF. A) RNA was purified from cultures of ONS-
76 cells treated with either DMSO or resveratrol and assayed for Zhangfei, trkA, 
Egr1, NGF and GAPDH transcripts by qRT-PCR. Bars represent standard 
deviations from the mean. For Zhangfei the histogram represent the mean of 
quadruplicate samples, for trkA and Egr1 the values are from duplicate samples. 
Bars represent standard deviation from the mean values from independent 
experiments, each in duplicate (5 experiments for Zhangfei, 4 for trkA and 3 for 
Egr1 and NGF). B) To determine if resveratrol-treated cells contained NGF, 
lysates of DMSO or resveratrol treated ONS-76 cells were added to PC12 cells. 
As a control PC12 cells received no treatment (middle panel) or were treated 
with NGF (top panel). Forty-eight hours later cells were photographed. Arrows 
indicate neurite-like projections sprouting from PC12 cells in response to NGF 
or lysate from resveratrol-treated ONS-76 cells. 
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Figure 4.3. Ectopic expression of Zhangfei in growing ONS-76 cells leads 
to the suppression of their growth and expression of TrkA and Egr1. ONS-
76 cells were either mock-infected (MI) or infected with adenovirus vectors 
expressing beta-galactosidase (Ad-LacZ) or Zhangfei (Ad-ZF). A) Viable cells in 
triplicate samples were counted at the time of infection and for four days 
following infection. B) RNA extracted from infected cells was extracted 48 hr 
after infection and assayed for Zhangfei, trkA, Egr1 and GAPDH. Bars represent 
the mean of triplicate samples. C)  RNA was extracted from ONS cells infected 
with adenovirus vectors expressing beta-galactosidase, Zhangfei or Zhangfei 
(Y224A), a mutant that does not bind HCF. Transcripts for trkA and Egr1 and 
GAPDH were assayed. D) Micrographs (20X) of ONS-76 cells infected with 
either adeno-LacZ or adeno-ZF. Cells were photographed 48 hr after infection.
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Figure 4.4. Zhangfei leads to the phosphorylation of Erk1 in ONS-76 cells.  
ONS-76 cells were treated with either DMSO or 100 µM resveratrol or were 
infected with adenovirus vectors expressing beta-galactosidase (Ad-LacZ) or 
Zhangfei (Ad-ZF). Proteins in cell lysates were separated by SDS-PAGE and 
probed with antibodies against Erk1/2 (top panel). The bound antibodies were 
then stripped and the blot reprobed with antibodies specific for phosphorylated 
Erk1 (lower panel).  
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Figure 4.5. Resveratrol and ectopic Zhangfei induce apoptosis in ONS-76 
cells. ONS-76 cells were treated with either DMSO or resveratrol or were 
infected with adenovirus vectors expressing either beta-galactosidase or 
Zhangfei. Twenty four hours after treatment or infection, cultures were analyzed 
for apoptotic cells by examining cells for Caspase 3 or Annexin V. Numbers in 
the figures represent percent of cells expressing these markers of apoptosis. 
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Figure 4.6. Effect of resveratrol or Zhangfei on growth of human diploid 
fibroblasts (MRC5) and medulloblastoma cells (UW228). MRC5 (A) or 
UW228 (B) cells were treated with either DMSO or resveratrol or were infected 
with adenovirus vectors expressing either beta-galactosidase (Lac-Z) or 
Zhangfei (ZF). Viable cells were counted, daily for three days after treatment or 
infection. 
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Figure 4.7. Potential role for Zhangfei in the establishment and 
maintenance of HSV latency, a model: A herpes simplex virion including its 
tegument (grey zone surrounding the hexagon representing the nucleocapsid) 
travels by retrograde transport along microtubules to the neuronal cell body. 
Here, Zhangfei suppresses the ability of VP16 to initiate viral Immediate Early 
gene expression and, consequently, the lytic cycle. In the uninfected neuron 
Zhangfei induces the expression of trkA, which is transported to cell 
membranes. Interaction of NGF with cell-membrane associated TrKA initiates 
signalling pathways that maintain homeostasis and in neurons with latent HSV-1 
induce conditions that help to maintain the HSV genome in a latent state. 
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5. GENERAL DISCUSSION AND CONCLUSIONS 
 
Nerve growth factor is a critical neutrophin required during development 
for survival, proliferation and differentiation of neurons (Parada et al., 1992, 
Greene and Kaplan, 1995, Kaplan and Miller, 2000, Huang and Reichardt, 
2003). Nerve growth factor (NGF) actions are attributed mainly to the activation 
of its receptor tropomyosin related kinase trkA, generally expressed in neurons 
of the peripheral and central nervous system (Huang and Reichardt, 2003). 
NGF-trkA binding allows autophosphrylation of its cytoplasmic tail (C-terminal) 
activating a number of signaling pathways that regulate gene expression. In 
adults, NGF is no longer required for survival and is believed to play a role in the 
maintenance of homeostasis of neurons or in sprouting of neurons after tissue 
injury (reviewed in (Lei and Parada, 2007)). But more importantly, NGF is 
thought to mediate the inflammatory and immune response after tissue injury 
(damage) or by recognizing other noxious stimuli.  The trkA neutrophin receptor 
and the downstream intracellular signaling pathways mediate sensitizing actions 
of NGF in mature   nociceptive neurons. 
 
NGF, like many other factors is produced by and acts on several types of 
cells. TrkA receptors are usually located at the peripheral termini of sensory 
neurons and are activated by NGF released by mast cells, macrophages, 
keratinocytes and T cells located near the site of tissue trauma, by cell in the 
shin and muscle  and by glial cells neighboring the body of the sensory neuron. 
It has been proposed that HSV-1 latency is sensitive to NGF signal transduction 
(Hill et al., 1997)  and that these latently infected medium and small diameter 
sensory neurons would express the TrkA (Yang et al., 2000). 
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Initial infection by HSV-1 is generally associated with lesions in and 
around the mouth, characterized by a group of small blisters or watery vesicles 
on the skin or on mucous membranes (virus replication - lytic phase). These 
lesions are preceded by tingling and burning in the skin area. The vesicles 
break and the skin appears normal within 6 to 10 days after the onset of the 
lesion (virus enters latency in sensory neurons). Lesions may often reappear 
(reactivation of the virus from latency) at the same site for many years and may 
be precipitated by any one of a number of factors, such as sunburn, upper-
respiratory and gastrointestinal tract infections, fevers, emotional stress, or 
anxiety. 
 
The aim of this study was to contribute to the understanding of the 
mechanisms, in sensory nociceptive neurons, that link the NGF/TrkA signaling 
cascade with the maintenance of HSV latency and reactivation from it.  Based 
on the observations that NGF is normally upregulated in target cells upon 
sensing noxious stimulus (chemical or emotional stress, injury, fever among 
others) and that HSV reactivates in vitro when deprived of NGF, it would be 
plausible to hypothesize that reactivation of HSV is triggered by a 
downregulation of the TrkA receptor, disrupting NGF signaling cascade, rather 
than by a decrease in the availability of NGF. 
 
To date most of the information related to HSV infection has addressed 
the molecular biology of the virus life cycle (lytic and latent state) in epithelial 
cells and in neurons in vitro and in vivo (reviewed in (Roizman, 2001, Efstathiou 
and Preston, 2005). Although, there is detailed information available on the host 
cellular changes associated with HSV infection, it has been difficult to define 
direct roles for host proteins in cellular mechanisms associated with latency and 
reactivation.  Moreover, the specific mechanisms by which the latent virus 
senses stress have not been clearly defined. 
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Nevertheless, the chromatin associated protein Host cell factor 1 (HCF-1) 
is an essential for initiating the viral replicative cycle both in epithelial cells and 
in neurons (Luciano and Wilson, 2002). In epithelial cells it does so in 
association with the virion transactivator, VP16. While VP16 is responsible for 
lytic virus replication in epithelial cells it has been suggested that in neurons the 
process of reactivation from latency is regulated by a cellular factor that would 
replace VP16 function. VP16 is produced in the late phase of replication and 
only the viral genome is available at the time of reactivation in the sensory 
neuron. A search for cellular proteins that also require HCF for their cellular 
function and could be associated to HSV life cycle, led to the discovery of the 
proteins  Luman and Zhangfei. Luman is able to activate transcription of HSV IE 
in a manner similar to VP16 (Lu and Misra, 2000a) and Zhangfei is able to 
suppress transcription activation of genes by these proteins in an HCF 
dependant manner in vitro (Misra et al., 2005).  
 
Not only VP16 is absent during HSV latency in sensory neurons 
(reviewed in Valyi-Nagy et al. 2006) , HCF is located mainly   in the cytoplasm in 
these cells making it largely unavailable for HCF dependant nuclear function 
(Kristie et al., 1999). Knowing that under stress signals HCF is able to 
translocate to the nucleus  making it available for proteins that depend on its 
association for function, it is believed that HCF would be the most  appropriate 
and  critical switch from viral latency to reactivation.  
 
Based on the above previous findings it was  essential to further 
understand the role of  host proteins, in the context of triggering changes in 
neuron signaling pathways that have been associated to HSV reactivation from 
latency.  Since Zhangfei has shown to be a suppressor of viral and host proteins 
in an HCF dependant manner, it seemed likely that it would depend on HCF 
nuclear translocation to modify or alter   transcription activation of genes 
modifying neuronal signaling and possibly HSV latency.   
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The specific objective of this study was to contribute to the understanding 
of how Zhangfei regulates gene expression in the context of HSV-1 latency and 
reactivation. I demonstrate herein the ability of Zhangfei to regulate transcription 
activation of promoters in a cell type and promoter specific manner. 
 
Brn3a, a marker for neuronal development and differentiation, was 
selected in the search for other HCF binding proteins that could be regulated by 
Zhangfei and could also be associated with neuronal cellular processes. Brn3a 
has been extensively studied in the context of development in the mouse. 
Others have shown  that Brn3a acts ti enhance trkA transcription by binding to 2 
motifs in a 457 bp segment of the promoter. While attempting to confirm these 
results in the human I identified novel cis-acting domains in the proximal trkA 
promoter that bind Brn3a and showed that exogenous Brn3a could induce the 
expression of trkA in NGF-differentiated PC12 cells and in medulloblastoma 
cells that do not normally express trkA (Chapter 2). In addition, the Brn3a 
enhancer motifs found to be active during mouse development did not appear to  
activate the human trkA promoter indicating that not only is trkA transcription 
differentially regulated in a cell type specific manner, but  that it  is most  likely 
that Brn3a  has a distinctive role in NGF-trkA signaling during development and 
during differentiation  of nociceptive neurons. 
 
Brn3a’s trans-activation of TrkA requires HCF for activity, Zhangfei, 
known for its HCF dependant regulation of gene transactivation, suppressed 
Brn3a’s activity in non-neuronal cells while in neuron-like NGF-differentiated 
PC12 cells Zhangfei did not suppress Brn3a. Surprisingly, Zhangfei was 
capable of activating the expression of trkA in the absence of Brn3a and without 
the requirement of HCF in these differentiated cells. This evidence supports the 
hypothesis that Zhangfei like Brn3a also differentially regulates gene 
transcription in a cell type specific manner. In addition, my observation that in 
PC12 cells Zhangfei suppresses Luman while activating Brn3a, suggests that 
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Zhangfei has the ability to regulate transcription in a promoter specific manner 
as well (Chapter 3).  
 
The HCF dependency of Zhangfei to regulate Luman’s trans-activation of 
genes in PC12 cells suggests that this process is triggered in neurons upon 
stress when HCF is allowed to translocate to the nucleus. On the contrary, 
transcription activation of trkA by Zhangfei can occur with or without nuclear 
HCF indicating that either this is a regular cellular activation process 
(unstressed) or that Zhangfei upregulates trkA in order to restore normal NGF-
TrkA signaling after noxious stimuli. More importantly, these findings indicate 
that Zhangfei plays an important role   in the activation and/or maintenance of 
the NGF/trkA signaling cascade. 
 
TrkA induction has been widely studied during development and a series 
of suppressors and activators have been suggested for mouse in in vitro 
models.  In general, there little information on the human TrkA promoter 
activation, mainly because of the lack of appropriate human cell models to study 
it.  To demonstrate that Zhangfei was able to induce trkA gene transcription and 
had an effect on the NGF-trkA signaling pathway I used human 
medulloblastomas  (which do not normally express TrkA).  Zhangfei was able to 
induce TrkA transcription, activate phosphorylation of the intermediate kinase 
Erk1   allowing the transcription activation of the IE gene Egr1 (Chapter 4).  This 
confirms Zhangfei’s involvement in NGF signal transduction through the 
activation of trkA. 
 
Activation of the Erk1 pathway by TrkA phosphorylation has been 
implicated in hyperalgesia and in the sensitization of sensory neurons. In the 
context of HSV-1, reactivation has been associated with neuronal sensitization 
to temperature (fever), immune response (infection), hormone imbalance 
(emotional distress) and cytotoxicity (food intoxication). It is unknown how the 
  144 
virus senses these changes and which are the molecular thresholds considered 
by the virus to allow itself to reactivate.   
 
 This study has made an important contribution to the understanding of 
the possible role of Zhangfei on the NGF-TrkA signaling pathway and its 
association with HSV latency and reactivation.  Finding an appropriate in vitro 
cellular human model for establishment of HSV latency would allow to further 
study Zhangfei’s association with the virus life cycle.  Although Zhangfei is 
unable to bind DNA as a homodimer it has been demonstrate herein its ability to 
activate gene transcription. Several proteins have been suggested as 
heterodimer partners for Zhangfei. Further studies should identify Zhangfei’s 
partner involved in the activation of TrkA and if this activation is by direct or 
indirect binding to the proximal promoter.   Discovering the specific protein 
partner would also shed information   on the timing of Zhangfei’s participation in 
NGF signal transduction. 
 
General Conclusions: 
 
1. Novel Brn3a cis-acting sequences that are important for trkA trans-
activation. 
2. Zhangfei is able to influence NGF-trkA signaling and consequently may 
influence HSV latency and reactivation. 
3. It may be possible to control the growth of medulloblastomas by inducing 
the expression of Zhangfei 
 
The specific conclusions of this thesis are: 
 
Chapter 2: Brn3a transactivation of the trkA promoter  
• Brn3a  binding to the previously reported   5’  binding motif  in the trkA 
promoter in the 457 bp minimal developmental enhancer, does not 
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contribute to reporter gene activation in  the non-neuronal  Vero cell line 
nor in sympathetic neuron-like cells, PC12. 
• A short 190 bp region that lies proximal to the trkA coding sequence and 
does not overlap the 457 bp minimal developmental enhancer, is 
sufficient for Brn3a activation of the trkA promoter in non-neuronal as well 
as in neuronal cells.  
• Recombinant Brn3a, in the absence of other cellular proteins, binds 
directly to at least two portions of the 190 bp fragment. 
• Brn3a requires HCF for transcription activation of the trkA promoter in 
Vero cells. However, Brn3a does not bind to HCF in vitro.  
• Exogenous Brn3a activates the transcription of endogenous trkA in the 
sympathetic-like neuron PC12 and ONS76 medulloblastoma cells but not 
in Vero cells suggesting that this activation is tissue specific. 
 
Chapter 3: Zhangfei suppression of Brn3a transactivation of the trkA promoter  
•  As with Luman and VP16, Zhangfei suppresses Brn3a transactivation of 
trkA in an HCF dependant manner in Vero cells.  In contrast, in PC12 
cells Zhangfei has no repressive effects on Brn3a trans-activation 
function.  
• In PC12 cells Zhangfei activates the trkA minimal promoter and increases 
trkA endogenous transcription independent of HCF. In addition, Zhangfei 
suppresses Luman in these cells suggesting that Zhangfei’s role on gene 
transcription is cell-type as well as promoter specific. 
 
Chapter 4: Zhangfei activation of endogenous trkA in Medulloblastomas. 
• Resveratrol differentiated cells have elevated levels of Zhangfei, trkA and 
Egr1 compared with undifferentiated cells.  
• Infection of growing ONS-76 cells with an adenovirus vector expressing 
Zhangfei leads to the activation of trkA and Egr1 and may be responsible 
for the initiation of trkA-NGF signaling in these cells leading to either their 
differentiation or apoptosis. 
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• Resveratrol and Zhangfei differ in their effects on human diploid cells 
considered to be relatively normal in their growth characteristics. 
Resveratrol prevents these cells from growing while Zhangfei has no 
apparent effect supporting the hypothesis that Zhangfei cellular effects 
are cell type specific. 
 
Based on these observations I propose a hypothetical role for Zhangfei in 
the establishment of HSV-1 latency. In this model Zhangfei acts to promote HSV 
latency by suppressing VP16 and Luman induced expression of viral IE genes 
from herpesvirus genome delivered to the neuronal cell body. Zhangfei also acts 
to maintain latency by stimulating trkA expression and the NGF-trkA signaling 
pathway, probably accomplishing this as a partner of another b-Zip protein. 
 
Since NGF is produced by many cell types it is possible that reactivation 
is triggered not by a decrease in NGF but by a down-regulation of trkA 
expression. I hypothesize that this is brought about by stress related 
suppression or decrease in expression in neurons of Zhangfei. This would allow 
neuronal HCF-binding proteins such as Luman, which can activate HSV IE 
expression, to initiate HSV IE expression and subsequently viral replication. 
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